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SUMMARY 
Preterm birth is one of the most significant worldwide problems in perinatology. The 
limited viability of preterm infants have been advanced thanks to the ongoing development of 
neonatal intensive medicine, although the rates of mortality and morbidity vary according to 
gestational age. Beside mortality the challenges of preterm birth are associated with short-term 
morbidity during the neonatal period and moderate to severe long-term morbidity, such as 
childhood disabilities 1,2 and high financial burdens for the society 1. Preterm infants are 
spending the first period of their life in a neonatal intensive care unit (NICU), which is critical for 
their survival. However, this period is characterized by repeated pain exposure, which is 
occurring during the critical window of central nervous system development 3,4. Recurrent pain 
exposure during this critical time is associated with permanent changes in peripheral, spinal and 
supraspinal pain processing, neuroendocrine function and neurologic development 5,6. 
Furthermore, these changes can be manifested by alterations in pain thresholds, stress 
responses, cognitive function, behavioral disorders, and long-term disabilities in learning and 
dampened behavioral pain response 4,7-19. This information brought the pain expert community 
to recognition that efficient pain management in this population is critical for their future 
development.  
The average number of painful procedures preterm infants are exposed to in a NICU stands 
on +14 procedures per day 20-22, while most of these procedures being associated with minor to 
moderate pain. While pharmacological pain relief agents are appropriate for severe pain 
management, they are not adequate to manage minor and routine painful procedures such as heel-
stick 20. Furthermore, most of pain medications used for preterm infants in NICUs are off-label or 
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unlicensed for use in this population 23. Therefore, non-pharmacological pain relief interventions 
are proposed to overcome these challenges. These interventions include methods that involve 
reducing the sensitivity of the neonates during and after minor painful procedures (e.g. sucrose, 
non-nutritive sucking, kangaroo care, and facilitated tucking) 24,25. A number of studies have 
reported the efficacy of non-pharmacological pain relief interventions. Most of these studies, 
however, examined single painful events. Information is lacking regarding the comparative 
effectiveness of these interventions and their efficacy over time. In order to provide a basis for 
efficient pain management, comprehensive pain assessment is required.  
Pain assessment has gone through major development in the past decades 26, with more 
than two-dozen pain assessment instruments developed and evaluated. The recommendation is 
for comprehensive multidimensional assessment method, which include both behavioral (cry, 
facial expression) and physiological (heart rate, oxygen saturation) measures 27. Despite the 
major advances in pain assessment in neonates, challenges in understanding the behavior of 
pain in preterm infants remain. Pain response in preterm infants is variable within and between 
infants 22,28, and weak correlations are repeatedly reported between behavioral and 
physiological responses 28-30, which makes clinical interpretation of pain scores difficult. These 
phenomenon reinforce the belief that pain response in these vulnerable infants seems to involve 
more than the invasive procedure itself but is further influenced by demographic and medical 
contextual factors 20,22-24,45. In the past years the scientific pain expert community has widely 
recognized the issue of contextual factors associated with pain response. The results in the 
existing literature indicate that the contextual factors consistently associated most with pain 
responses of preterm infants are age related factors 31-40, previous pain exposure 15,31,34-36,39,41,42, 
and severity of illness 15,30,34-36,41-43. However, findings even in relation to these contextual factors 
are not consistent across studies. One explanation for this inconsistency is the varying 
methodological approaches used in these studies. Therefore, further research is needed to 
determine which contextual factors are most strongly associated with pain response and to 
progress one step further with more comprehensive pain assessment instruments.  
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The overall purpose of this project was to compare the effectiveness of two non-
pharmacological pain relief interventions over time, and to explore the association between 
medical and demographic contextual factors and pain response of preterm infants under the 
impact of non-pharmacological pain relief interventions during repeated routine heel-stick 
procedures.  
This thesis includes 7 chapters:  
Chapter I presents a comprehensive introduction into the relevance of pain in neonates, 
particularly in preterm infants. The chapter gives an overview of the problem of premature 
neonatal pain within the context of neurologic development in preterm infants. This leads to the 
issue of the serious short and long-term consequences of high pain exposure during the neonatal 
period. The challenges in pain assessment are described within the complexity of the neonatal 
pain experience in the NICU, leading to the importance of pain management with non-
pharmacological pain relief interventions. The last part of the introduction presents the 
theoretical framework this study was based on. Chapter II describes the specific aims of the 
dissertation. 
Chapter III presents a publication of the results of the parent study PAMINA (PAin 
Management In NeonAtes). PAMINA is multicenter randomized control trial (RCT) that aimed to 
compare the effectiveness of non-pharmacological pain relief interventions; oral sucrose and 
facilitated tucking, across 5 heel-stick procedures in preterm infants aged between 24 and 32 
weeks of gestation. Seventy-one infants were randomly allocated to one of three interventions: 
sucrose, facilitated tucking, or the combination of both interventions. Four experienced nurses, 
blinded to the phase of the heel-stick (baseline, heel-stick, and recovery) assessed pain with the 
Bernese Pain Scale for Neonates (BPSN). The results show that sucrose with and without 
facilitated tucking had pain-relieving effects even in preterm infants younger than 32 weeks of 
gestation and remained effective across time.  
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Chapter IV presents the publication of a commentary article about the intervention of 
facilitated tucking. In this manuscript we raise the question of the clinical feasibility of facilitated 
tucking, which requires additional manpower. In light of economic restraints of the health care 
system, and the lower effectiveness of facilitated tucking compared to sucrose, this commentary 
encourages re-evaluating the recommendations regarding methods such as facilitated tucking 
and further recommending for comparative effectiveness studies of non-pharmacological pain 
relief interventions. 
Chapter V presents the results of a systematic review, which examined studies investigating 
the impact of contextual factors on pain response of heel-stick procedures in preterm infants. A total 
of 23 studies meeting inclusion criteria were included in the review. The studies varied relative to 
their design, sample, analysis procedures, and variables examined. Six categories of contextual 
factors emerged: age, pain exposure, health status, therapeutic interventions, behavioral status, and 
demographic factors. The review supports the influence of some contextual factors on pain response 
with the factors most consistently related to pain response being age related factors, previous pain 
exposure and severity of illness. The examined contextual factors varied in the strength of their 
association with pain response, and none were consistently related, as evidenced by contradictory 
findings. In some cases the inconsistencies appeared attributable to the methodological 
heterogeneity of the studies included in the review. The results of the review also support the low 
correlation between behavioral and physiological pain responses, and the need for further 
investigation of contextual factors, to better understand their influence on pain response.   
Chapter VI presents the results manuscript of the exploratory sub analysis of the PAMINA 
study. This study aimed to explore the association of contextual factors with pain response of 
preterm infants receiving non-pharmacological interventions for repeated heel-stick procedures. 
In total 10 demographic and medical CFs were extracted from medical charts over the first 14 
days of life. In this study we confirmed the low correlation between behavioral and physiologic 
pain scores in preterm infants. The results of the study emphasize that higher exposure to 
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painful procedures; male infants and having CPAP or mechanical ventilation were the contextual 
factors associated with physiological responses. The only variables that were significantly 
associated with the behavioral scores of the Bernese Pain Scale for Neonates, were Apgar scores 
at 1 and 5 minutes, however these relationships were inconsistent.  In this study we examined a 
variety of contextual factors that previous studies have suggested may influence preterm infants' 
pain responses. The use of multivariate analysis while controlling for potential confounders 
allowed us to examine the independent contribution of each examined contextual factor in 
explaining pain responses. Furthermore, we utilized a pain assessment instrument that allowed 
us to examine the impact of the contextual factors on both behavioral and physiologic pain 
responses. Our findings also add to the growing body of research that suggests the need to 
considering contextual factors when assessing pain in this population. However, given that 
findings about the impact of CFs are mixed across studies, additional multicenter research 
including large sample is needed to determine the contextual factors that need to be 
incorporated into pain assessment instruments.  
Finally in Chapter VII the results of all study parts are synthesized and discussed, 
followed by suggestions for further research and clinical practice development. Pain assessment 
and management remains a major challenge in preterm infants. The findings of this dissertation 
support the efficacy of sucrose over time and recommend it over facilitated tucking. While our 
findings support the importance of considering contextual factors as influencing pain responses 
in this vulnerable population, the specific contextual factors that need to be incorporated into 
pain assessment scales remains unclear. Our findings raise important methodological issues that 
need to be considered as future studies are designed to examine the impact of contextual factors 
on pain responses of preterm infants. 
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1. INTRODUCTION 
1.1 PROBLEM STATEMENT 
Preterm birth is defined as birth occurring before completing 37 weeks of gestation 1. 
Preterm birth rates have increased since the early 1980s both worldwide (9.6%) and in 
industrialized countries including the USA (12-13%) and European countries (5-9%) with 
Switzerland having a prematurity incidence rate of 7.1% 2-6. Preterm birth is one of the most 
significant problems in perinatology. These infants require neonatal intensive care in order to 
ensure their survival and improve their outcomes. After neonatal intensive care unit (NICU) 
admission, preterm infants often face increased medical challenges and are neurodevelopmentally 
less prepared to cope with multiple stimuli such as recurrent procedural pain. 
Preterm infants, particularly the youngest and most vulnerable ones with extremely low 
birth weight are exposed to both major and minor painful procedures 7,8. Findings from recent 
studies suggest that neonatal exposure to pain is extremely high during their hospitalization in 
the NICU and that the pain relieving methods utilized are often inadequate 7,9-11. Although the 
number of painful procedures that a neonate in the NICU is exposed to has decreased during the 
past decades and use of analgesic has increased 12, pain management during NICU procedures 
still generally falls short of current pain management guidelines 12,13. Some NICUs still have no 
standard protocols of pain management during routine minor painful procedures such as heel-
sticks 14. Inadequate pain management is known to have negative effects on the motor and 
cognitive development of this patient population 15,16. Preterm infants’ vulnerability related to 
inadequate pain management is associated with their neurologic immaturity and the high 
plasticity of their central nervous system. Repeated pain exposures during the critical windows 
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of central nervous system development can lead to chronic changes of the cytoarchitecture of 
the brain. These changes can be manifested in later childhood by alterations of cognitive 
function, behavioral disorders and long-term disabilities 17-19. 
1.2 NEUROLOGIC DEVELOPMENT OF PRETERM INFANTS 
Pain as an unpleasant sensorial experience has been scientifically recognized in neonates 
only since the mid 80ies 20; this recognition led to a paradigmatic change in the perception of 
pain in neonates. Since then, it is widely accepted that fetal pain perception begins in the third 
trimester of pregnancy 21-24. Behavioral pain expression is seen in preterm infants as young as 
24 weeks gestation 25,26. It has also become clear that the nervous system undergoes extensive 
postnatal development 27 and there is increasing evidence that repeated pain exposure as a 
result of common therapeutic or diagnostic procedures in the NICU setting may lead to serious 
alterations during the sensitive developmental phase of the central nervous system, as 
demonstrated in many human and animal studies 28-39.  
Nociceptive neural circuits are formed during the embryonic and the early postnatal 
period, a time when painful events are normally absent or limited. In a series of animal 
experiments, Ruda and colleagues 29 found that peripheral localized pain and inflammation 
experienced during the neonatal period has an impact on the nociceptive neural circuitry 
development, which is responsible of pain processing in the spinal dorsal horn. Furthermore, 
peripheral tissue injury can lead to a state of hyperalgesia and allodynia in which noxious 
responses are enhanced 40 and general sensitivity to subsequent pain is altered 21.   
One of the reasons for the extreme vulnerability of the developing premature brain is its 
neuroplasticity. Neuroplasticity can be defined as the property the brain has in terms of the 
extent to which nerve cells and neural networks are able to modify their structure, 
network connectivity and/or operating mode in response to changes in intrinsic (genetic or 
lesions) or extrinsic (environmental changes) events. This malleability of the brain structure and 
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function is mainly attributed to the developing brain in premature newborns 41. The developing 
nervous system is in a critical vulnerable period of growth from the 20th week of gestation 
through the first 18-24 month of life. This period is characterized by dendritic arborization, 
axonal growth, myelination, peak synaptogenesis, gliogenesis, and maturation of the 
mechanisms and structures involved in synapsis neurotransmission 42,43. 
There is some evidence to suggest that preterm neonates may be more sensitive to pain 
than more mature infants. They show a lower tactile threshold than term infants with additional 
decreases in the threshold after repeated exposure to painful stimuli 44,45. Furthermore, there is 
increasing evidence that repeated exposure to pain may lead to serious changes during the 
sensitive developmental phase of the central nervous system, as demonstrated in several human 
and animal studies 28-39 and that tissue injury, e.g. related to therapeutic or diagnostic 
procedures, in the early neonatal period can cause profound and long-lasting changes in the pain 
thresholds and subsequent patterns of pain processing 17-19. The frequency of exposure to pain 
and the adequacy of pain management are, therefore, critical issues in the care of preterm 
infants both in terms of their comfort and motor and cognitive development. 
1.3 THE INFLUENCES OF PAIN ON THE DEVELOPING BRAIN AND ON 
BEHAVIORAL PATTERNS OF PREMATURE INFANTS 
1.3.1 Short term effects of pain exposure on physiologic and  
 behavioral changes 
Studies in animals and humans have shown a number of negative short-term 
consequences of painful procedures during the premature neonatal phase. These consequences 
include decreased levels of plasma cortisol 35; increased levels of catecholamines, aldosterone, 
glucagon, and growth hormone 21,46; decreased oxygen saturation 47-49; increase in heart rate 47,49-
52; higher sensitivity to cutaneous stimuli 44; and transient (5-60 seconds) decreases in cerebral 
blood flow of 20% to 50% 36. Despite the negative effects of exposure to repeated noxious 
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procedures, studies have shown that preterm infants’ behavior pain responses are often 
blunted. Johnston and Stevens 49 reported that infants who had undergone frequent invasive 
procedures during their hospitalization displayed less intense facial responses to heel-stick 
procedures when compared to infants who had undergone fewer procedures. A possible 
explanation for this change of behavioral patterns is the synactive theory proposed by Als 53-55. 
The theory assumes that preterm infants’ behavior is their primary route for communicating 
stress. However, during their hospitalization in NICU preterm infants’ behavior becomes 
disorganized under the extreme stress of preterm birth followed by intensive care treatment. As 
a consequence of the exhaustion resulting from extreme stress and repeated painful procedures, 
they are not able to respond coherently to noxious stimuli. Fitzgerald 40 provided explanation for 
this altered pain reactivity in premature neonates based on understandings of the physiological 
processes, which shape the newborn pain response. Animal and human studies have 
demonstrated that reflex thresholds are low in newborns and there is an absence of the normal 
inhibitory control that mature brain structures would exert. As a result, premature neonates 
display more diffuse responses to noxious stimuli rather than more complex affective reactions 
27. Further evidence from both animal and human studies suggest that the early and repetitive 
pain experiences of premature newborns may affect future pain processing by altering 
nociceptive circuitry in the CNS 40. A study by Grunau et al. 56 examined demographic and 
therapeutic determinants of pain responses in 136 preterm infants between 23 to 32 weeks of 
gestation. They showed that diminished behavioral and autonomic pain responses were 
primarily a function of high exposure to previous invasive procedures and gestational age at 
birth. The authors further elucidated how much pain experience is required to shift the 
subsequent response. Exposure to 20 invasive procedures may be enough at this stage of 
development to convert an infant from a stimulus-naïve responder to a stimulus non-naïve 
responder. Cignacco et al. 9 examined the number of procedures ventilated preterm infants were 
exposed to during their first 14 days of life. They found that the infants were exposed to an 
average of 23 procedures a day of which 17 were associated with pain. Based on these findings 
INTRODUCTION 
28 
and those of Grunau et al. 56 it can be assumed that infants are converted from stimulus-naïve 
responder to a stimulus non-naïve responder within the first 2 days of NICU hospitalization and 
are, therefore, at high risk for negative consequences. 
1.3.2 Long lasting effects of pain exposure on ex-premature infants 
The long-term consequences of pain for preterm infants are mainly related to the high 
plasticity of the developing premature brain 40,57. Evidence suggests that early experiences with 
pain are associated with altered pain responses later in infancy 28,30,31,37,38,58,59. Furthermore, animal 
research suggests that some of these responses may last into adulthood 40 due to the influence of 
pain on the nociceptive pathways 60,61. The type and effect of the alteration in pain responses 
depend on the developmental maturity of the infant at the time the pain occurred, clinical factors 
such as the length and extent of exposure to pain, and other contextual factors (medical and 
environmental) during the time of pain exposure 62. In studies of newborn animals, skin wounds 
triggering pain had prolonged nociceptive effects. Wounds remained hypersensitive long after 
they healed 63, and the increases in the size of the dorsal horn receptive field were present for 
about six weeks after the injury 64. In studies of rats, repeated skin breaking and heat injuries lead 
to generalized hypoalgesia in adulthood 65,66. In other studies, this hypoalgesia effect was only seen 
when the mechanical and thermal injury occurred within the first 10 days of life 39,40. In a human 
study by Andrews and Fitzgerald it was found that receptive fields are wider the younger the 
gestational age (GA) of the infant is, which results in a more widespread sensitivity 44. 
Preterm birth results in long hospitalization of the infant who is physiologically unprepared 
for stress exposure outside the protective intrauterine environment 67. Hermann and colleagues 58 
compared 19 former preterms (GA <31 weeks) to 20 full-term children (both groups undergone 
NICU hospitalization), and 20 healthy full-term control children (at the time of the study all 
children were 9-14 years old). They found that the NICU groups had significant enhanced 
sensitization to painful thermal stimulation compared to the term control group. Repeated pain 
experience during the neonatal period may induce changes in the functioning of pain pathways 
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that persist way beyond infancy. Former preterm infants had significantly more tender points and 
lower tender point thresholds at 12 – 18 years of age than former full-term infants 59. There is 
evidence to suggest that repeated pain exposure during the neonatal period may lead to cognitive 
limitations in learning as well as behavioral consequences (more fear during surgery in childhood 
as well as signs of post-traumatic stress disorders) 16. Other studies reported subtle alterations in 
parasympathetic, sympathetic and initial behavioral reactions to acute pain in former low birth 
weight infants 31,37,38. Grunau et al. 15 proposed mechanisms by which perinatal pain in preterm 
infants may lead to a long-term negative impact on normal brain development. One of these 
mechanisms is that excitoxic damage may lead to altered apoptosis (programmed cell death) and 
neuronal survival. Bhutta et al 68 conducted a meta-analysis of 15 case-control studies examining 
cognitive and/or behavioral data of children born prematurely and evaluated after their fifth 
birthday. Children born prematurely had significantly lower cognitive test scores (p<.001) than 
control children and there was a significant correlation between test scores and birth weight (R2 = 
0.52, p < 0.001) and GA (R2 = 0.49, p < 0.001). In addition, children born preterm had a 2.64 
increased risk of developing ADHD (attention deficit hyperactivity disorders) compared to the 
control children and manifested internalizing (e.g. anxiety, depression) or externalizing (e.g. 
hyperactivity, delinquency) behaviors more often than control children. Although these studies did 
not specifically examine the impact of prenatal pain on later cognitive and behavioral function, it 
may be one of the multiple components of the NICU experience (pain, severity of illness, 
medication exposure, etc.) that cumulatively have a negative impact on later function 15. 
To conclude, pain exposure during this vulnerable period of central nervous system 
development is critical and needs to be addressed by comprehensive pain management strategies 
(which includes assessment and treatment). Pain management in preterm infants has been, and 
still is, a major challenge as it is lacking with a systematic approach despite the existing 
recommendations. Furthermore, due to the extreme immaturity of this population, pain response 
is highly variable and may involve many external factors, which hamper (effective) pain 
assessment and treatment.  
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1.4 PAIN MANAGEMENT 
1.4.1 Challenges of pain assessment in preterm infants 
A new conceptualization of pain by McCaffery 69 about 40 years ago made patients the 
experts in their pain by defining self-report as the pain assessment gold standard; “Pain is what 
the person says it is and exists whenever he or she say it does”. However, in a non-verbal 
population such as neonates, this definition cannot be applied. As a result, neonates are highly 
depending on pain assessment performed by health care providers.   
Many pain assessment instruments have been created to measure pain in this population. 
The purpose of the measurement of pain is to discriminate between pain and no pain, and to 
provide a picture of experienced pain that is as complete as possible and include some 
quantification of the pain. Measurement and assessment of pain are crucial in protecting the 
neonate from harm and deleterious consequences of the many painful diagnostic and 
therapeutic procedures in the clinical settings. Unfortunately, to-date none of the existing 
instrument have been designated as the gold standard. Despite tremendous advances in the 
development of pain assessment instruments for neonates, the challenge of measuring pain in 
preterms remains as a result of infants’ inability to verbally report their level of pain 70 and their 
responses being less vigorous, more variable and less consistent than term infants 71. In light of 
the infants’ inability of self-report, pain assessment instruments must be multidimensional 
incorporating both physiological and behavioral indicators 70 which will provide maximal 
information 72. A multidimensional measurement approach can be accomplished by 
simultaneously employing both subjective (e.g. assessment of facial activity) and objective  
(e.g. heart rate) data and by utilizing multiple dimensions within a particular measurement 
domain73. Behavioral responses to pain can be measured with crying, facial activity and body 
movements. Common physiological responses to pain are assessed through changes in heart 
rate, respiratory rate, blood pressure, oxygen saturation, and palmar sweating 74. Johnston and 
Stevens 49 reported that while preterm infants hospitalized in NICU demonstrated physiological 
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changes such as decreases in oxygen saturation and increases in heart rate in response to pain, 
their behavioral responsiveness was blunted. The behavioral responses of the preterm infants in 
the Johnson and Stevens’s study 49 were associated with the amount of exposure to pain, 
whereas the physiological responses were associated with the GA at birth and postnatal age 
(PNA). Many studies have explored the influence of contextual factors (CFs) such as GA, severity 
of illness related factors, behavioral state, and demographic factors on pain responses 71,72,74,75.  
1.4.2 Contextual factors associated with pain response of preterm infants 
Studies support the influence of CFs on pain responses in preterm infants. Several studies 
suggest that both GA and PNA affect behavioral pain response. Studies have reported that as GA 
increases, preterm infants’ responsiveness to pain increases as well 49,52,75,76. Gibbins et al. 48 
compared pain responses in infants of different GAs. They collected physiological and behavioral 
data during a routine heel-stick from four age groups (<27 6/7 weeks; 28-31 6/7 weeks; 32-35 
6/7 weeks and >36 weeks). All infants showed behavioral (facial) activities. The magnitude of 
response was proportional to the GA with the youngest group showing the least amount of 
changes. Decreases in oxygen saturation and increased heart rate were observed during the 
acute phase of the heel-stick with no statistically significant differences across age groups. These 
findings are supported by other studies, suggesting that the cephalocaudal development of facial 
musculature might influence the magnitude of facial activity as evidenced by the fact that 
preterm infant have less muscular strength, posture, tone, and body movement compared to 
term infants 35,47,77. Both Johnston and Stevens 49, & Anand and Scalzo 78 found that the number 
of invasive procedures an infant had undergone was the greatest predictor of decreased 
behavioral response to pain. Johnston and Stevens compared two groups of preterm infants, one 
born at 28 weeks of gestation and assessed at 32 weeks the second born at 32 weeks and 
assessed within 4 days. The first group had an increased physiological response and a decrease 
behavioral response to pain. The primary factor that explained the results was former pain 
experiences. The Apgar score was the secondary factor related to pain response 49. Reduced pain 
response based on number of painful procedures has a variety of explanations. In another study 
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of Johnston et al. 75 they stated that one of the explanations for the reduced response to pain, 
might be the proximity to the last painful procedure.  They hypothesized that the production of 
endorphins in response to the first procedure might have protected the infant from the pain of 
the following painful procedure. Infants with a very low GA (24-28 weeks) were found to have a 
higher procedural exposure due to their general immaturity and need for a higher degree of 
intensive care interventions 9. According to Johnston and colleges 75 the blunted pain responses 
in very preterm neonates may also be sign of exhaustion from all of the procedures and handling 
that the preterm infant experiences during hospitalization in the NICU. These CFs and others are 
suggested as explanatory factors for the variability in pain response between and within 
preterm infants and the low correlation between behavioral and physiologic responses 49,52,79. 
Although there is a wide range of validated pain assessment instruments for neonates, pain 
assessment in preterm infants remains a challenge. Cignacco et al. 80 reported high intra-infant 
variability in pain responses across repeated heel-sticks, which make pain assessment even 
more challenging. One possible explanation for this variability is in variations of external factors 
that affect the behavioral and physiological parameters of pain. Another important issue to be 
considered in pain assessment is the findings of either no or weak correlations between 
behavioral and physiologic pain responses 70,76,79,81. A low correlation was also reported between 
behavioral measures and cortisol 82. This phenomenon of variability in pain responses may also 
be explained by the contextual factors as mentioned above. 
1.4.3 Further pain assessment techniques 
In addition to evaluating pain using observational pain instruments, other bio-physiologic 
methods have been proposed to measure pain responses.  One of the methods proposed is 
cortisol measurement. Cortisol can be measured as a biomarker for pain-related stress response. 
In humans, cortisol is the primary glucocorticoid of the hypothalamic-pituitary-adrenocortical 
(HPA) system. The primary effect of cortisol is to stimulate hepatic gluconeogenesis, which 
increases the available energy 83. Another effect is to stimulate brain tissue in the regions where 
cortisol and its precursors are located, which may in turn, influence emotions and learning 84. 
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Studies examining cortisol responses to pain in preterm infants are inconsistent with some 
studies reporting higher levels and others reporting lower levels.  An additional method for 
physiological pain assessment is the near infrared spectroscopy (NIRS). NIRS is a non-invasive 
technique that can detect subtle changes in oxygenated (HbO2) and de-oxygenated (HbH) 
hemoglobin. Studies comparing NIRS to functional magnetic resonance imaging or positron 
emission scans demonstrate that it is a reliable method of monitoring cortical activation during 
functional studies 89. Bartocci et al. 85 used NIRS to determine whether acute pain activated the 
somatosensory cortex in preterm neonates. The painful procedure used during this study was a 
venipuncture. They demonstrated increases in HbO2 concentrations in both hemispheres during 
the painful stimulation. However this technique is not well validated as a measure of pain in 
preterm infants and required more research. 
To conclude, secondary to the complex nature of the pain response in preterm infants and 
consistent reports of low correlations between behavioral and physiological dimensions, one 
must use a comprehensive pain assessment approach that includes multiple dimensions. 
Multidimensional approaches to pain assessment may increase the probability of detecting pain 
in preterm infants, which is critical to effective pain management 70. 
1.4.4 Pain treatment  
Pain management is a basic human right 86, however, in infants is viewed as inadequate in 
the context of acute diagnostic and therapeutic procedures in the NICU 87,88. Approaches to pain 
treatment in preterm infants include both pharmacological and non-pharmacological methods.  
1.4.5 Pharmacological pain relieving interventions 
Most of the pain medications used for preterm infants in NICUs are off-label or unlicensed for 
use in this population 89. The pharmacological methods, which are mainly used for major procedural 
pain (e.g. surgery) in NICUs, include Morphine, Fentanyl, and Paracetamol. Morphine is the most 
widely used pharmacological agent in the NICU 9. However, the efficacy of Morphine in managing 
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pain in preterm infants is unclear and can have many negative adverse effects. In a randomized 
controlled trial (RCT) 11 focusing on pain relief in ventilated preterm infants during endotracheal 
suction, Morphine was not associated with pain relief as measured by three pain assessment scales. 
Another RCT comparing placebo to Morphine for analgesia in ventilated preterm neonates failed to 
show any beneficial effect of Morphine infusion compared to placebo. In an open-label study, 
Morphine was associated with a significant increase in illness severity and a longer length of 
ventilation and NICU hospitalization compared to the placebo group 90. While pharmacological 
interventions are considered appropriate for severe pain, they are too strong and not recommended 
for the treatment of minor and routine painful procedures (e.g. heel-stick) 7.  
There are recurrent reports that an average preterm infant hospitalized in NICU 
undergoes a mean of 14 painful and uncomfortable interventions per day 8,10,79,91.  Recent studies 
report that pain is still poorly managed in NICUs 7,12 despite evidences about the negative short 
and long term consequences of pain. There is also a growing body of research that suggest that 
simple non-pharmacological methods provide effective pain relief during many routine NICU 
procedures 92,93. 
1.4.6 Non-pharmacological pain relieving interventions 
Non-pharmacological interventions (NPIs) for pain prevention and relief are increasingly 
recommended for routine minor painful procedures in the NICU. These interventions include 
methods that involve reducing the sensitivity of the neonates during and after minor painful 
procedures92,93. Many NPIs have been proposed to control pain in infants including sucrose breast-
feeding, non-nutritive sucking, kangaroo care, facilitated tucking (FT), music, positioning, and 
swaddling. As our research compared sucrose and FT, we will focus on those two NPIs. The 
hypothesized mechanism underling the effectiveness of oral sucrose is that the sweet taste induces 
the release of endogenous opioids 94-98. FT is gentle positioning of the infant’s arms and legs in a 
flexed midline position (see figure 1 and 2 in chapter 4). This technique provides the infant with 
support and the chance to control his/her own body 99. In a resent Cochrane review, Stevens et al. 
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93 examined evidence about the efficacy of oral sucrose. Their findings from 41 RCTs showed that 
oral sucrose reduced pain associated with single minor painful procedure. In another Cochrane 
review of 51 RCTs examining the efficacy of NPIs (non-nutritive sucking related interventions, 
kangaroo care, swaddling, and FT), Pillai Riddell et al. 92 reported sufficient significant evidences 
supporting the effectiveness of these NPIs. However, most of studies on the effectiveness of NPIs in 
relieving pain have examined them for single painful procedure. There is little evidence about the 
effectiveness of NPIs over time. 
To summarize, preterm infants are exposed to a very high number of painful procedures 
during their stay in NICU. A large body of evidence point to a short and long-term negative 
effects of this exposure. These findings beg for appropriate pain management of this vulnerable 
population. While NPIs such as oral sucrose and FT has been extensively evaluated and shown to 
be effective and safe for pain relief during single painful procedures 9,47,91,96,99-111, there is a lack 
of evidences regarding the effectiveness of these interventions over time. Moreover, pain 
measurement is a complex issue and there is growing evidence that pain response in preterm 
infants is variable and may be influenced by many external medical and demographic factors, so 
called Contextual Factors (CFs). The CFs mentioned the most in the current literature are GA and 
PNA 112, and the number of previous painful procedures that the infant undergoes across the 
time of hospitalization in the NICU 113. Findings in relation to the impact of CFs on pain 
responses, are however inconsistent and requires further research.  
There is a need for a deeper understanding of the factors that influence the response, 
assessment and treatment of pain in preterm infants. External factors are important in pain 
response as well as its assessment and treatment.  In order to recognize the complexity of pain 
management, we embedded our research within a conceptual framework and choose to use the 
Socio Communication Model of Infants’ Pain 114.  
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1.5 CONCEPTUAL FRAMEWORK: THE SOCIO COMMUNICATION 
MODEL OF INFANT’S PAIN 
Craig and Pillai Riddell 114 provide a basis for conceptualizing infant pain within a socio 
communication model. In humans, pain rarely relates to the individual only, and is always 
embedded in a complex social context. From an anthropologic perspective, the individual’s 
ecologic system is embedded in a set of constructs, which are nested each inside the next, like a set 
of Russian dolls. The inner most level is the individual person. Each level represents a system that 
plays an important role in the individual’s life. These systems interact with each other with some 
having more direct influence and some being more distal 115. These levels can be represented by 
the family, ethnic identity, religion, community, culture, and race. The individual experience of 
pain is usually of profound importance to others, and has automatic transparent features (e.g. cry, 
speech) that serve social communication functions 116,117. Humans are relatively unique in their 
ability to express pain through a combination of language skills, facial expression and body 
movements. The interaction between an individual in pain and an observer during an acute painful 
event can have important impact on the outcomes for the person in pain 114, especially during 
infancy and childhood, when children face challenges of establishing secure attachments to 
primary caregivers 118,119. During this critical phase of development, recurrent and prolonged pain 
could influence bonding, feelings of security, and trust in others. Furthermore, persons suffering 
from persistent pain at any age may experience social isolation, diminished opportunities to 
interact with others, loss of skills, and even be at a risk of becoming stigmatized 114,120. However, 
the external social parameters of pain are more meaningful when pain is considered in older 
infants and young children.  
In their model (Figure 1), Craig and Pillai Riddell suggest that pain should be viewed as a 
dynamic and interactive process between the infant and caregiver, which is also influenced by 
the social context. In this model, there are three central features: the painful event, the child, and 
the caregiver. These central features are influenced by the familial, community, and cultural 
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environments. Each layer influences every other layer directly or indirectly (familial, community 
and cultural contexts). In addition to influencing each other, these contexts also influences the 
caregiver and child experiencing and expressing the painful event. 
Figure 1: The Socio-Communication Model of Infants’ Pain 
 
 
 
 
 
 
 
 
 
 
 
In the model, the solid lines around the child and the caregiver represent a synthesis of the 
social influences, which are created in all individuals because of their biological/personal factors 
and their position in their family, community, and culture. Furthermore, when the model refers to 
culture, it is considered in a broad perspective. In an era of globalization and fluid immigration 
between countries and continents, culture not only refers to the culture heritage of the individual, 
but also to the complexity of integrating one’s culture in another environmental culture. 
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In light of the complexity of premature infants’ pain, and considering that these infants are 
hospitalized in a NICU setting from birth, as well as the importance of CFs influencing pain 
response, the model was modified for the purpose of this thesis. We adapted the model to a NICU 
environment where the infant’s primary care givers are not the parents and the family, but rather 
the health care providers. We elaborated the model, by changing the layers surrounding the two 
core features, the infant and the caregiver, by placing the health care team and unit culture in the 
first circle.  Furthermore, we added the immediate influence of medical and demographic factors 
on the infant’s pain. The modified model is presented in chapter 5. 
This dissertation will address gaps in the literature by: 
 Presenting results of the randomized controlled parent study examining the 
comparative effectiveness of two non-pharmacological pain relief interventions: 
oral sucrose and facilitated tucking alone, and in combination for repeated pain 
exposure in preterm infants (chapter 3). 
 Providing a commentary point of view regarding the clinical feasibility of 
facilitated tucking (chapter 4). 
 Presenting a systematic review of evidence describing the association between 
medical and demographic contextual factors and pain response in preterm infants 
during heel-stick procedures (chapter 5). 
 Examining the association between contextual factors and pain responses in 
preterm infants under the therapeutic effect of the non-pharmacological 
interventions (examined in chapter 3) (chapter 6). 
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2. STUDY AIMS 
2.1 PARENT STUDY (CHAPTER III) 
Preterm infants are exposed to numerous minor and moderated painful procedures on a 
daily basis. This exposure may cause short and long lasting negative effects on the developing 
nervous system. To address this problem non-pharmacological pain relieving interventions 
(NPIs) are recommended to prevent and treat pain. Despite studies supporting the efficacy of 
NPIs for single painful procedures, there is a lack of evidence regarding the effectiveness of NPIs 
over repeated pain exposure. The aim of this study, therefore, was to test the comparative 
effectiveness of two non-pharmacological pain relieving interventions, sucrose and facilitated 
tucking administered alone or in combination across 5 repeated heel-sticks in preterm infants 
aged between 24 and 32 weeks of gestation. 
Figure 1: Flow chart for recruitment and randomization 
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2.2 SYSTEMATIC REVIEW (CHAPTER V) 
The importance of medical and demographic contextual factors (CFs) associated with pain 
response of preterm infants has been recognized and explored by the neonatal pain researchers 
and are of great concern for accurate pain measurement and assessment. However, the influence 
of CFs related to medical and demographic determinants remains unclear to date. The aim of this 
study was to systematically examine, identify, and summarize the impact of medical and 
demographic CFs on pain response in preterm infants exposed to heel-stick procedures. 
2.3 SUB STUDY (CHAPTER VI) 
Given the present challenges of pain assessment and treatment in preterm infant 
population as presented in the introduction chapter, there is a need to address the 
phenomenon of CFs in pain management research in this vulnerable population. CFs were 
studied however so far the results remains unclear. The aim of this study was to explore the 
association between CFs and pain response of preterm infants age 24-32 weeks of gestation 
being treated with NPIs. This is the first study to examine the association between a wide 
range of medical and demographic CFs and multidimensional pain responses.  
 
 
 
 
  
STUDY AIMS 
54 
Figure 2: Contextual factors influencing pain response under the therapeutic effect of  
 non-pharmacological pain relief intervention. 
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ABSTRACT 
Objectives: To test the comparative effectiveness of two non-pharmacological pain-
relieving interventions administered alone or in combination across time for repeated heel-sticks 
in preterm infants. 
Patients and Methods: A multicenter randomized controlled trial in three NICU’s in 
Switzerland compared the effectiveness of oral sucrose, facilitated tucking (FT), and a 
combination of both interventions in preterm infants between 24 and 32 weeks of gestation. 
Data were collected during the first 14 days of their NICU stay. Three phases (baseline, heel-
stick, recovery) of 5 heel-stick procedures were videotaped for each infant. Four independent 
experienced nurses blinded to the heel-stick phase rated 1055 video sequences presented in 
random order utilizing the Bernese Pain Scale for Neonates (BPSN), a validated pain assessment 
instrument. 
Results: Seventy-one infants were included in the study. Inter-rater reliability was high 
for the total BPSN score (Cronbach’s alpha: α = 0.90-0.95). FT alone was significantly less 
effective in relieving repeated procedural pain (p<0.002) than sucrose (0.2ml/kg). FT in 
combination with sucrose seemed to have added value in the recovery phase with lower pain 
scores (p=0.003) compared to both single treatment groups. There were no significant 
differences in pain responses across gestational ages. 
Conclusions: Sucrose with and without FT had pain-relieving effects even in preterms less 
than 32 weeks of gestation having repeated pain exposures. These interventions remained 
effective during repeated heel-sticks across time. FT was not as effective and cannot be 
recommended as a non-pharmacological pain relief intervention for repeated pain exposure.  
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3.1 BACKGROUND 
The survival of preterm infants is dependent on highly sophisticated intensive care 
associated with an exceedingly high number of painful procedures 1. This is particularly true for 
infants with extremely low gestational ages (GA) who also receive less analgesia 2-5.  
Repeated pain exposures during critical windows of central nervous system development are 
associated with permanent changes in peripheral, spinal and supraspinal pain processing; 
neuroendocrine function and neurologic development 6,7. These changes can be manifested by 
alterations in pain thresholds, stresses responses, cognitive function, behavioral disorders and long-
term disabilities 7,8. Despite this knowledge, many painful procedures in neonatal intensive care 
units (NICU) are performed without pharmacologic or non-pharmacological analgesia 1-3,9. 
Disadvantages of pharmacological analgesia include side effects, questionable efficacy and possible 
negative impact on neonatal outcomes 10-12. As an alternative approach, non-pharmacological 
interventions (NPIs) are recommended for pain management 13-15.  
NPIs (e.g. oral sucrose, breastfeeding, non-nutritive sucking, facilitated tucking (FT), 
kangaroo care, swaddling) effectively reduce pain for minor to moderately painful procedures 15-17. 
They promote self-regulation of the infant and provide oro-tactile, oro-gustatory and tactile 
stimulation, capable of reducing infants’ pain responses during most painful procedures 15,18-21. 
Sucrose is recommended extensively for pain relief in preterm infants 22-24 and shown to be highly 
effective and safe for single procedures by Stevens and collegues 17. Sweet taste solutions seem to 
trigger endogenous opioids and non-opioids pathways 25,26. FT is described as holding the infant by 
placing a hand on his hands and feet and by positioning the infant in a flexed midline position whiles 
in either a side-lying, supine, or prone position 27,28. This technique provides the infant with support 
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and the chance to control his/her own body 16. Several studies reported that FT stabilizes behavioral 
and physiological states, during single heel-sticks and endotracheal suctioning, reducing the infant’s 
stress in coping with pain 16,27-31.  
Although current evidence supports the effectiveness of NPIs for a single painful 
procedure, there is little research examining their effectiveness across repeated painful 
procedures. To date, few studies have evaluated the effectiveness of sucrose over time 32-36, and 
none have evaluated FT across time. The combination of two NPIs (e.g. oral sucrose and FT) may 
have additive effects by stimulating infants in a multi-sensorial way to cope with the painful 
experience 18,37, 38. 
This study compared the impact of sucrose and FT alone and in combination on pain 
reactivity across multiple painful procedures. Randomized groups received oral sucrose, FT, and 
a combination of both strategies in order to evaluate possible additive effects. The primary 
outcome was pain response measured by the “Bernese Pain Scale for Neonates” (BPSN) total and 
component scores. The secondary outcome was the impact of gestational groups (24 0/7 - 27 
6/7 and 28 0/7 - 32 0/7 gestational weeks) on the effectiveness of these interventions. 
3.2 METHODS 
3.2.1 Setting and sample 
This randomized controlled trial was carried out in NICUs of three University Hospitals in 
Switzerland from January 12th to December 31st 2009. Infants admitted to the NICU during this 
period were assessed for eligibility according to the following inclusion criteria: born between 
24 0/7 and 32 0/7 weeks of gestation and anticipated clinical need for at least 5 routine 
capillary blood samples within two weeks after birth. Infants were excluded if they had sever 
intra-ventricular hemorrhage (grade III and IV), life-threatening malformations or disorders 
affecting brain circulation or the cardiovascular system, undergone a surgical procedure, a 
pH<7.00, or any problem that could impair pain expression.   
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3.2.2 Sample size calculation 
Using sucrose only, we performed a feasibility study to calculate a preliminary power-
analysis 39. We formulated our calculations based on the assumptions that sucrose and FT will 
have equivalent effects, which will sustain over time. According to this analysis, a group size of 
n=24 for each intervention group (n=72 total sample size) provided adequate power to detect a 
pain reduction of 33% for the combination group relative to the two single intervention groups 
with a power of 80%. 
3.2.3 Data collection and management 
Data were collected during five nonconsecutive routine heel-sticks (T1-T5) between 
postnatal days 2 and 16, with the first heel-stick performed no later than day 4. For other painful 
procedures including heel-sticks where data were not being collected the infants were provided 
with sucrose 20%, which was the standard of care in all-participating NICUs. Because the timing 
of blood sampling was determined by clinical considerations, there were no fixed time points for 
data collection. Demographic data were collected from medical records. 
Data collection occurred during: (1) baseline (before any manipulation), (2) heel-stick 
(skin preparation, heel-stick, and hemostasis after blood was drawn), and (3) recovery (3 
minutes after the heel-stick). Most heel-sticks took place in the morning and each infant was 
undisturbed for at least 30 minutes prior to data collection. Phases were videotaped (Panasonic 
high definition camcorder, model HDC-HS9., Osaka, Japan) for at least 3 minutes by trained study 
nurse using a standardized procedure. No recording occurred during heel warming (2-3 
minutes) between the first and second phases. The infant’s nurse performed the heel-stick. 
Sucrose was administrated by the nurse, while the FT was performed by a second nurse or 
trained study nurse. The exact time of the videotaping of each phase was documented as well as 
the duration of heel-sticks. Fifteen videotape segments were produced per infant (3 sequences 
per procedure x 5 heel-sticks = a total of 1065 video sequences for the study).  
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Each video segment was checked for quality and digitally edited by trained study nurses 
using the Final Cut Express software (version 4.0.1.® 2002-2008 Apple Inc., California, USA) to 
eliminate any information that would have indicated the heel-stick phase. Video recordings of 
poor quality were discarded (n=10). The final sample of 1055 sequences was assigned in 
random order in relation to the number (T1 – T5) and the phase (baseline, heel-stick, recovery) 
of the heel-stick being recorded. All digital records were provided to 4 nurses for assessment of 
pain responses during each sequence.  The videotaping procedure was designed to ensure that 
the raters could not see if the heel-stick procedure was being performed.  
The NPI groups were: (1) oral sucrose 20% (0.2ml/kg) (2) FT and (3) a combination of 
both interventions. Sucrose was administrated orally about two minutes prior to the heel-stick. 
If the infant seemed to be in pain during the heel-stick phase, up to two additional doses of 
sucrose were administrated and noted in the study chart. FT was started at the beginning of the 
baseline phase, and the infant was “tucked” through all three phases. In the combination group, 
the FT was started at the beginning of the baseline phase and sucrose was given two minutes 
before the heel-stick.  
3.2.4 Variables and measures 
Information about GA, method of delivery, gender, parity, birth weight, Apgar scores, 
mechanical ventilation or continuous positive airway pressure )CPAP) during the heel-stick, and 
number of painful procedures each day was collected.  
Pain response, the dependent variable, was measured using the BPSN total and component 
scores. The BPSN contains 9 items, three physiologic (heart rate, respiratory rate, and oxygen 
saturation) and six behavioral (grimacing, body movements, crying, skin color, sleeping patterns, 
consolation) items. Physiological data (heart rate and oxygen saturation) synchronized with the 
three phases of data collection were downloaded from the clinical monitoring database for the 
BPSN. Raters counted the breathing rate while viewing the video sequences. Raters scored 
behavioral items and breathing only; heart rate and oxygen saturation were scored using 
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physiological data collected during each phase.  Each item was scored on a 3-point scale (0-3 
points). Higher scores for the behavioral items and greater changes in the physiological items 
indicated increased pain, while a total score of  11 was considered non-painful 40. The neonatal 
nursing experts who rated the video sequences attended a standardized instruction session about 
how to perform the rating and they rated the sequences independently. 
Initial psychometric testing of the BPSN demonstrated good construct validity with 
differentiation between painful and non-painful procedures (F = 41.27, p < 0.0001) and intra-rater 
and inter-rater reliability correlation coefficients of r = 0.98-0.99 and r = 0.86-0.97 respectively. In 
a recent revalidation of the BPSN, a cut-off- score of  11 was considered non-painful (sensitivity of 
100 % and specificity of 89.4%) 41.  For this study, three BPSN scores were calculated: the total (T-
BPSN), behavioral (B-BPSN), and physiological (P-BPSN) BPSN scores. 
3.2.5 Inter-Rater-Agreement 
Inter-rater reliability for the total BPSN scores in this study averaged 99.2% for the 5 heel-
sticks (range: 98.8% for heel-stick 1 and 99.8% for heel-stick 5). Since the inter-rater reliability 
was very high, we used the average raters’ BPSN scores within infants over time (5 heel-sticks). 
Within-infant variability in total BPSN scores across time was high (86.3%, p < 0.0001). Inter-rater 
reliability for behavioral BPSN scores was 98.8%. Inter-rater reliability, measured by Cronbach’s 
alpha coefficient, ranged between 0.90 and 0.95 for the different phases.  
3.2.6 Randomization 
To assure equal balance of the intervention group per site, block randomization using 
SPSS® (version 16) was performed. For each site, 8 infants were randomly allocated to each of 
the three interventions (24 infants per site, and 24 infants per intervention group for the entire 
study sample). For each site, group assignments were sealed in opaque envelopes and 
consecutively numbered. When parents consented to participation, the envelope was opened by 
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a study nurse and the intervention group was revealed. Envelopes were prepared by a study 
nurse not involved in the data collection process.  
During the study period, 201 infants less than 32 weeks of gestation were assessed for 
eligibility to participate in the study. In each site a study nurse called the referring NICU daily 
and asked if any new infants were eligible to participate in the study.   
3.2.7 Ethical Consideration  
The study was approved by the ethical boards of the Cantons of Basel, Bern and Zürich. 
Written informed consent was obtained from a parent. The study design did not include a no-
intervention control group based on the evidence that exposure of preterm infants to pain 
procedures without treatment is harmful 14.  
3.2.8 Data analysis procedures 
All data were analyzed using IBM SPSS statistics software® (version 19) and SAS (version 
9.1). Data entry quality was controlled by double-entry procedures and an error rate of < 1% was 
detected.  Descriptive statistics were utilized to describe the demographic and medical 
characteristics of the infants while the chi-square test (χ²), and Kruskal-Wallis or Mann-Whitney U 
tests were utilized for comparisons between the three intervention groups and the two GA groups.  
The mean number of painful procedures was compared per site per infant per day, utilizing one-
way ANOVA and post hoc Tukey test. Correlations between physiological and behavioral items of 
the BPSN were calculated with the Pearson coefficient. Clinical site, GA group, number of painful 
procedures and heel-stick duration were examined as possible confounders on the impact of the 
NPIs on BPSN scores; none had a confound effect. The primary hypothesis was tested using a 
repeated measure analysis. We used a random slopes regression model, which allowed each 
subject to have its own regression over the five heel-sticks. Due to high inter-rater reliability, 
scores of the four raters were averaged and transformed logarithmically to satisfy the assumption 
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of normally distributed residuals. For comparisons between the three phases, scores across the 
five heel-sticks were also averaged. An alpha of 0.05 was considered significant.  
3.3 RESULTS 
3.3.1 Sample characteristics and number of daily procedures 
Seventy-one infants were enrolled in the study and all but one had complete data. The fifth heel-
stick was missed for one infant. Figure 1 presents the flow diagram of the recruitment and 
randomization process based the Consolidated Standards of Reporting Trials (CONSORT) guidelines 42.  
Figure 1: Flow diagram of the recruitment and randomization process 
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The mean GA of the participating infants at birth was 29.2 (SD +1.8) weeks, mean birth 
weight was 1174 grams (SD +337), and mean number of painful procedures during 0-14 days 
was 201 (SD +104). Sample characteristics are summarized in Table 1.  
Table 1: Demographic and medical characteristics of the sample  
 Total 
Sample 
Non-pharmacological intervention group 
 Sucrose FT Combination χ² 
  n (%) n (%) n (%) n (%) 
Sample 71(100) 24 (33.8) 24 (33.8) 23 (32.4) p=0.986 
Gender     p=0.983 
Female 32 (45.0) 11(45.8) 11 (45.8) 10 (43.5)  
Male 39 (55.0) 13 (54.2) 13 (54.2) 13 (56.5)  
Way of delivery     p=0.805 
Normal birth 6 (8.5) 3 (12.5) 1 (4.2) 2 (8.7)  
Planned C-section 16 (22.5) 4 (16.7) 6 (25.0) 6 (26.1)  
Emergency C-section 49 (69.0) 17 (70.8) 17 (70.8) 15 (65.2)  
Parity     p=0.462 
Single 50 (70.4) 19 (79.2) 14 (58.3) 17 (73.9)  
One of twins 14 (19.7) 3 (12.5) 8 (33.3) 3 (13.0)  
One of triplet 5 (7.0) 2 (8.3) 1 (4.2) 2 (8.7)  
One of quadruplet 2 (2.8) 0 (0) 1 (4.2) 1 (4.3)  
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Kruskal-
Wallis 
GA at birth 
(weeks and days) 
29.24 (1.8) 28.95 (1.7) 29.20 (1.7) 29.5 (2) p=0.389 
Duration of heel-stick (min)      
HS 1 5.04 (5.2) 4.38 (3.8) 4.12 (3.6) 6.7 (7.4) p=0.687 
HS 2 4.75 (4.3) 4.54 (4.5) 4.67 (3.5) 5.04 (5.0) p=0.851 
HS 3 5.01 (4.8) 4.46 (3.1) 4.95 (4.7) 5.65 (6.2) p=0.878 
HS 4 4.73 (3.7) 5 (3.9) 5.33 (4.0) 3.83 (3) p=0.305 
HS 5 4.77 (3.6) 4.65 (3.7) 5.38 (4.1) 4.26 (2.9) p=0.751 
Birth weight (gr) 1174.44 
(337) 
1080 (286) 1228 (397) 1217 (309) p=0.308 
APGAR scores      
1 min 5.97 (2.1) 5.65 (2.3) 5.46 (2.3) 6.83 (1.6) p=0.070 
5 min 7.58 (1.6) 7.21 (1.4) 7.29 (1.8) 8.26 (1.2) p=0.030* 
Number of painful 
procedures per day  
14.38 (7.4) 15 (10) 15 (9) 13 (9) p=0.012* 
Number of heel-sticks per 
infants per day 
1.07 (1.2) 1 (1) 1 (1) 1 (1) p=0.539 
*The significance level is 0.05 
 FT= facilitated tucking GA=gestational age SD= standard deviation  
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3.3.2 Testing the effectiveness of the non-pharmacological interventions 
We compared the effectiveness of sucrose, FT and their combination in reducing pain 
responses during heel-stick procedures. Table 2 presents the mean scores of the total, 
behavioral and physiological BPSN scores for the three intervention groups.  
Table 2:  Mean pain scores for all raters across all heel-sticks measured by  
  the Bernese Pain Scale for Neonates (BPSN) 
  Non-pharmacological intervention group 
  Sucrose FT Combination 
Score Phase Mean SD Mean SD Mean SD 
T-BPSN Baseline 4.03 2.08 4.99 3.24 4.62 2.88 
 Heel-stick 7.48 3.64 9.75 4.73 7.53 3.75 
  Recovery 4.87 2.04 5.18 2.87 4.23 2.68 
B-BPSN Baseline 4.02 2.08 4.97 3.25 4.62 2.88 
 Heel-stick 5.58 2.95 7.01 3.59 5.49 2.95 
  Recovery 3.66 1.71 3.9 2.47 3.18 2.24 
P-BPSN Baseline 0 0 0.04 0.22 0 0.03 
 Heel-stick 1.89 1.79 2.72 1.98 2.03 1.73 
  Recovery 1.23 1.35 1.28 1.31 1.05 1.23 
T-BPSN= total BPSN scores B-BPSN= behavioral BPSN scores P-BPSN= physiological BPSN scores  
FT= Facilitated tucking SD= standard deviation  
The correlation between the infants' mean behavioral and physiological pain scores across 
the raters and phases of the heel-stick was low (r = 0.19). Effectiveness of the interventions was 
examined by comparing mean pain responses over all heel-sticks. Figure 2 presents the mean 
behavioral and physiological pain scores over all 5 heel-sticks as predicted by the regression 
analysis. During heel-stick phase, the FT group had significantly higher B-BPSN (p = 0.01; 0.007) 
and P-BPSN (p = 0.0002; 0.003) scores than the sucrose and combination groups. During the 
recovery phase, there were no significant differences in P-BPSN scores, but the combination 
group had significantly lower B-BPSN scores than both the other groups (p = 0.006; 0.008).  
Figure 3 shows how the B-BPSN and P-BPSN of heel-stick phase scores for each group 
changes across the five heel-sticks. P-BPSN scores for the FT group increased significantly from 
heel-stick 1 to 5 (p = 0.01), while there were no significant changes for the sucrose (p = 0.08) and 
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Non-pharmacological intervention group:  
 : Sucrose  : Facilitated tucking  : Combination 
combination (p = 0.43) groups. Overall B-BPSN scores showed no significant changes over time, 
but the slope between heel-stick 1 and 2 decreased significantly (p = 0.01) for the FT group and the 
slope between heel-stick 4 and 5 increased significantly (p = 0.03) for the sucrose group.  
Figure 2: Slope testing-non-pharmacological intervention groups and phases 
Behavioral score measured by the BPSN 
 
 
 
 
 
 
 
 
 
*The significance level is 0.05 
Phase 1= baseline Phase 2= heel-stick Phase 3= recovery SE= Standard error df= degrees of freedom  
   Physiological BPSN scores Estimate       SE df t-value p-value 
Phase 1 to 2 Facilitated tucking (FT) Point a versus b -0.3644 0.06915 905 -5.27 <.0001* 
 Sucrose Point g versus h -0.2882 0.06858 905 -4.2 <.0001* 
 Combination Point d versus e -0.1753 0.06947 905 -2.52 0.0118* 
Phase 1 FT – Sucrose  Point a versus g -0.1478 0.08839 905 -1.67 0.0948 
 FT – Combination Point a versus d -0.05171 0.08911 905 -0.58 0.5618 
 Sucrose – Combination Point d versus g 0.09612 0.0891 905 1.08 0.281 
Phase 2 FT – Sucrose  Point b versus e -0.224 0.08873 905 -2.53 0.0117* 
 Sucrose – Combination Point h versus e 0.01679 0.08907 905 0.19 0.8506 
 FT – Combination Point b versus h 0.2408 0.08947 905 2.69 0.0072* 
Phase 3 Sucrose – Combination Point f versus i 0.2433 0.08896 905 2.73 0.0064* 
 FT – Combination Point c versus i 0.2356 0.08886 905 2.65 0.0082* 
 FT – Sucrose  Point c versus f 0.007718 0.08801 905 0.09 0.9301 
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Non-pharmacological intervention group:  
 : Sucrose  : Facilitated tucking  : Combination 
Physiological score measured by BPSN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The significance level is 0.05* 
Phase 1= baseline Phase 2= heel-stick Phase 3= recovery SE= Standard error df= degrees of freedom 
 
 
In the sucrose and combination groups (n = 47), 21 infants (44.7%) received additional doses 
of sucrose. During heel-stick phase, infants who received additional doses of sucrose had 
significantly higher B-BPSN scores than those who did not receive additional doses (p = 0.02), while 
their P-BPSN scores were not significantly different (p = 0.50). There were no significant differences 
in the recovery phase behavioral (p = 0.85) or physiological (p = 0.26) pain scores of infants who did 
or did not receive additional doses of sucrose. 
 Physiological BPSN scores Estimate SE df t-value p-value 
Phase 1 to 2 Facilitated tucking (FT) Point a versus b -1.1101 0.06304 905 -17.61 <.0001* 
 Sucrose Point g versus h -0.8767 0.06258 905 -14.01 <.0001* 
 Combination Point d versus e -0.9265 0.06339 905 -14.62 <.0001* 
Phase 1 FT – Sucrose  Point a versus g -0.02477 0.06867 905 -0.36 0.7184 
 FT – Combination Point a versus d -0.02193 0.06916 905 -0.32 0.7512 
 Sucrose – Combination Point d versus g 0.002840 0.06916 905 0.04 0.9673 
Phase 2 FT – Sucrose  Point b versus e -0.2581 0.06905 905 -3.74 0.0002* 
 Sucrose – Combination Point h versus e -0.05262 0.06915 905 -0.76 0.4468 
 FT – Combination Point b versus h 0.2055 0.06955 905 2.95 0.0032* 
Phase 3 Sucrose – Combination Point f versus i 0.08641 0.06903 905 1.25 0.2110 
 FT – Combination Point c versus i 0.1068 0.06891 905 1.55 0.1214 
 FT – Sucrose  Point c versus f -0.02042 0.06829 905 -0.30 0.7650 
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Non-pharmacological intervention group:  
 : Sucrose  : Facilitated tucking  : Combination 
Figure 3:  Pain scores over the heel-sticks for phase 2 (heel-stick) measured by the Bernese Pain 
Scale for Neonates (BPSN) 
 
Behavioral score measured by the BPSN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physiological score measured by BPSN 
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3.4 DISCUSSION  
The findings of this study show that either sucrose alone or sucrose in combination with FT 
remains effective across five heel-sticks in preterm infants under 32 weeks of gestation, while FT 
alone appears to be less effective. Furthermore, the results indicate that the combination of 
sucrose and FT may have additive pain relieving effects during the recovery phase.  
Our findings are consistent with previous studies regarding the efficacy of sucrose over 
time 32-35. No sign of tolerance to the analgesic effects of sucrose was observed. It is important to 
note that FT was not lacking efficacy but rather was less effective than the two other 
interventions. The mean T-BPSN and B-BPSN scores during all phases were less than 10 points, 
even for infants in the FT group. Previous data suggest that a T-BPSN score ≤11 points or a B-
BPSN score <8 points is considered as “no pain”. The efficacy of FT has been described in several 
studies 16,27-29,43, although these studies did not compare FT with other NPIs. Our study is the 
first to compare the efficacy of FT or sucrose across time, to its efficacy when used in 
combination with sucrose.  
Infants in the sucrose and combination groups who received additional doses of sucrose 
had significantly higher behavioral pain scores across all 5 heel-sticks. Regardless these findings, 
there were no differences in recovery phase between infants who did or did not receive 
additional doses of sucrose. Our findings correspond to those of Johnston and colleagues 44, who 
examined the effects of repeated doses of sucrose in preterm infants receiving sucrose solution 
or sterile water either 2 minutes before, just before, or 2 minutes after the heel-stick. Their 
results showed that repeated doses of sucrose, at 2 minutes intervals increases the analgesic 
effect in preterm infants. 
Another previous randomized trial questioned the analgesic efficacy of sucrose, based on 
EEG and EMG recordings in healthy term newborns (37–43 weeks), receiving sucrose or sterile 
water 2 minutes prior to a heel-stick. Slater et al. 45 found no differences in nociceptive brain 
activity or in the magnitude or latency of the spinal nociceptive reflexes after the heel-stick, 
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between infants who received sucrose and those who received water, although Premature Infant 
Pain Profile (PIPP) scores and pain-related facial expressions were significantly reduced in the 
sucrose-treated infants. These findings contradict data from a large body of literature 
supporting the analgesic efficacy of sucrose or other sweet solutions. Moreover, there are 
several methodological concerns related to the Slater et al. study that make it seem premature to 
conclude that sucrose is ineffective based only on its findings 46.  
Although the differences between the sucrose and combination groups in behavioral and 
physiological scores during the recovery phase were statistically significant, the magnitude of 
these differences is probably not clinically meaningful. This poses a critical question related to 
the cost-effectiveness of this intervention. FT is a time consuming intervention, which could be 
used as a procedure to enhance parenting or bonding, but needs to be questioned as a nursing 
intervention. Although there are promising findings regarding FT as an effective NPI 30, the 
challenges of this specific intervention in nursing practice need to be re-considered in an 
environment characterized by economic constraints 47. 
The methodological strengths of this study are the strategies undertaken to enhance the 
internal validity of these results. The use of 4 trained and experienced nurses to perform pain 
assessment, the randomization of the sequences in order to blind the raters to the phase of the 
procedure, and the thorough elaboration of each single video sequence reduced potential biases.  
However, there are some methodological limitations in this study. The raters could only be 
partially blinded to the NPI group due to the clear visibility of the FT procedure, which could 
cause possible bias. Nevertheless, raters did not know if the infant was in the FT only group or in 
the combination group. A further limitation was the exclusion of a no intervention control group 
due to ethical considerations. Long-term consequences of repeated doses of sucrose were 
investigated in a small number of studies, but there are no conclusive findings regarding the risk 
for poor neurological outcomes. In the present study we did not follow up infants for 
neurological outcomes. Further research regarding consequences of prolonged use of sucrose is 
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needed. Another limitation of this study was that although the original protocol was for infants 
in the FT only group to receive FT for all painful procedures during the time they were enrolled 
in the study, staff shortages made it impossible for nurses to implement this procedure 
consistently for non-study painful procedures 47. Consequently, these infants were treated with 
oral sucrose 20% (the standard of care in the units) for non-study procedures. The impact that 
this had on the efficacy of FT alone is unknown but it is possible that consistent use of this 
procedure may have altered its efficacy.  
3.5 CONCLUSIONS 
The results of this randomized controlled trial provide evidence that oral sucrose alone or 
combined with FT remains effective in reducing heel-stick related pain over time in preterm 
infants (24-32 weeks), during the critical phase of the first 14 days of NICU stay. These findings 
have important clinical implications for the management of pain in preterms of low GA, who are 
at risk for a high frequency of painful procedures during their NICU stay. During the recovery 
phase of the heel-stick, the combination of FT and oral sucrose was slightly more effective in 
reducing pain than sucrose alone. This difference was not however; clinically meaningful 
particularly given the additional resources needed to implement the combined intervention.   
  
PAMINA – RANDOMIZED CONTROL TRIAL 
72 
3.6 REFERENCES 
1. Cignacco E, Hamers J, van Lingen RA, et al. Neonatal procedural pain exposure and pain 
management in ventilated preterm infants during the first 14 days of life. Swiss Med Wkly 
2009;139:226-32. 
2. Simons SH, van Dijk M, Anand KS, Roofthooft D, van Lingen RA, Tibboel D. Do we still hurt 
newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch 
Pediatr Adolesc Med 2003;157:1058-64. 
3. Carbajal R, Rousset A, Danan C, et al. Epidemiology and treatment of painful procedures in 
neonates in intensive care units. JAMA 2008;300:60-70. 
4. Johnston C, Barrington KJ, Taddio A, Carbajal R, Filion F. Pain in Canadian NICUs: have we 
improved over the past 12 years? Clin J Pain 2011;27:225-32. 
5. Stevens B, McGrath P, Ballantyne M, et al. Influence of risk of neurological impairment and 
procedure invasiveness on health professionals' management of procedural pain in 
neonates. Eur J Pain 2010;14:735-41. 
6. Anand KJS. Pain, plasticity, and premature birth: a prescription for permanent suffering? 
Nat Med 2000;6:971-3. 
7. Anand KJ, Scalzo FM. Can adverse neonatal experiences alter brain development and 
subsequent behavior? Biology of the neonate 2000;77:69-82. 
8. Grunau RE, Tu MT. Long-term consequences of pain in human neonates. In: Anand KJ, 
Syevens B, McGrath P, eds. Pain in neonates and infants. 3rd ed. Philadelphia: Elsevir; 
2007:44-5. 
9. Badr LK, Abdallah B, Hawari M, et al. Determinants of premature infant pain responses to 
heel sticks. Pediatr Nurs 2010;36:129-36. 
10. Anand KJ, Barton BA, McIntosh N, et al. Analgesia and sedation in preterm neonates who 
require ventilatory support: results from the NOPAIN trial. Neonatal Outcome and 
Prolonged Analgesia in Neonates. Archives of pediatrics & adolescent medicine 
1999;153:331-8. 
PAMINA – RANDOMIZED CONTROL TRIAL 
73 
11. Simons SH, van Dijk M, van Lingen RA, et al. Routine morphine infusion in preterm 
newborns who received ventilatory support: a randomized controlled trial. JAMA 
2003;290:2419-27. 
12. Anand KJS, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: 
primary outcomes from the NEOPAIN randomised trial. Lancet 2004;363:1673-82. 
13. Batton DG, Barrington KJ, Wallman C. Prevention and management of pain in the neonate: 
an update. Pediatrics 2006;118:2231-41. 
14. Anand KJS. International Evidence-Based Group for Neonatal P. Consensus statement for 
the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med 
2001;155:173-80. 
15. Cignacco E, Hamers JP, Stoffel L, et al. The efficacy of non-pharmacological interventions in 
the management of procedural pain in preterm and term neonates. A systematic literature 
review. Eur J Pain 2007;11:139-52. 
16. Axelin A, Salantera S, Lehtonen L. 'Facilitated tucking by parents' in pain management of 
preterm infants-a randomized crossover trial. Early Hum Dev 2006;82:241-7. 
17. Stevens B, Yamada J, Ohlsson A. Sucrose for analgesia in newborn infants undergoing 
painful procedures. Cochrane Database Syst Rev 2010:CD001069. 
18. Bellieni CV, Buonocore G, Nenci A, Franci N, Cordelli DM, Bagnoli F. Sensorial saturation: 
an effective analgesic tool for heel-prick in preterm infants: a prospective randomized 
trial. Biol Neonate 2001;80:15-8. 
19. Stevens B, Gibbins S, Franck LS. Treatment of pain in the neonatal intensive care unit. 
Pediatr Clin North Am 2000;47:633-50. 
20. Als H, Gilkerson L, Duffy FH, et al. A three-center, randomized, controlled trial of individualized 
developmental care for very low birth weight preterm infants: medical, neurodevelopmental, 
parenting, and caregiving effects. J Dev Behav Pediatr 2003;24:399-408. 
21. Carbajal R, Chauvet X, Couderc S, Olivier-Martin M. Randomised trial of analgesic effects of 
sucrose, glucose, and pacifiers in term neonates. BMJ 1999;319:1393-7. 
PAMINA – RANDOMIZED CONTROL TRIAL 
74 
22. Lefrak L, Burch K, Caravantes R, et al. Sucrose analgesia: identifying potentially better 
practices. Pediatrics 2006;118 Suppl 2:S197-202. 
23. Blass EM, Watt LB. Suckling- and sucrose-induced analgesia in human newborns. Pain 
1999;83:611-23. 
24. Gibbins S, Stevens B, Hodnett E, Pinelli J, Ohlsson A, Darlington G. Efficacy and safety of sucrose 
for procedural pain relief in preterm and term neonates. Nurs Res 2002;51:375-82. 
25. Bach FW. Beta-endorphin in the brain. A role in nociception. Acta Anaesthesiol Scand 
1997;41:133-40. 
26. Blass EM, Ciaramitaro V. A new look at some old mechanisms in human newborns: taste and 
tactile determinants of state, affect, and action. Monogr Soc Res Child Dev 1994;59:I-V, 1-81. 
27. Corff KE, Seideman R, Venkataraman PS, Lutes L, Yates B. Facilitated tucking: a 
nonpharmacologic comfort measure for pain in preterm neonates. J Obstet Gynecol 
Neonatal Nurs 1995;24:143-7. 
28. Ward-Larson C, Horn RA, Gosnell F. The efficacy of facilitated tucking for relieving 
procedural pain of endotracheal suctioning in very low birthweight infants. MCN Am J 
Matern Child Nurs 2004;29:151-6; quiz 7-8. 
29. Huang CM, Tung WS, Kuo LL, Ying-Ju C. Comparison of pain responses of premature infants 
to the heelstick between containment and swaddling. J Nurs Res 2004;12:31-40. 
30. Obeidat H, Kahalaf I, Callister LC, Froelicher ES. Use of facilitated tucking for 
nonpharmacological pain management in preterm infants: a systematic review. J Perinat 
Neonatal Nurs 2009;23:372-7. 
31. Axelin A, Salantera S, Kirjavainen J, Lehtonen L. Oral glucose and parental holding preferable 
to opioid in pain management in preterm infants. Clin J Pain 2009;25:138-45. 
32. Johnston CC, Filion F, Snider L, et al. Routine sucrose analgesia during the first week of life in 
neonates younger than 31 weeks' postconceptional age. Pediatrics 2002;110:523-8. 
PAMINA – RANDOMIZED CONTROL TRIAL 
75 
33. Stevens B, Yamada J, Beyene J, et al. Consistent management of repeated procedural pain 
with sucrose in preterm neonates: Is it effective and safe for repeated use over time? Clin J 
Pain 2005;21:543-8. 
34. Harrison D, Loughnan P, Manias E, Gordon I, Johnston L. Repeated doses of sucrose in 
infants continue to reduce procedural pain during prolonged hospitalizations. Nurs Res 
2009;58:427-34. 
35. Gaspardo CM, Miyase CI, Chimello JT, Martinez FE, Martins Linhares MB. Is pain relief 
equally efficacious and free of side effects with repeated doses of oral sucrose in preterm 
neonates? Pain 2008;137:16-25. 
36. Taddio A, Katz J. The effects of early pain experience in neonates on pain responses in 
infancy and childhood. Paediatr Drugs 2005;7:245-57. 
37. Bellieni CV, Cordelli DM, Marchi S, et al. Sensorial saturation for neonatal analgesia. Clin J 
Pain 2007;23:219-21. 
38. Chermont AG, Falcao LF, de Souza Silva EH, de Cassia Xavier Balda R, Guinsburg R. Skin-to-
skin contact and/or oral 25% dextrose for procedural pain relief for term newborn 
infants. Pediatrics 2009;124:e1101-7. 
39. Cignacco E, Denhaerynck K, Nelle M, Buhrer C, Engberg S. Variability in pain response to a 
non-pharmacological intervention across repeated routine pain exposure in preterm 
infants: a feasibility study. Acta Paediatr 2009. 
40. Cignacco E, Mueller R, Hamers JP, Gessler P. Pain assessment in the neonate using the 
Bernese Pain Scale for Neonates. Early Hum Dev 2004;78:125-31. 
41. Brunner C, Nelle M, Stoffel L, Cignacco E. Revalidation of the Bernese Pain Scale for 
Neonates. Basel: University of Basel; 2010. 
42. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: 
Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 
2010;63:e1-37. 
PAMINA – RANDOMIZED CONTROL TRIAL 
76 
43. Hill S, Engle S, Jorgensen J, Kralik A, Whitman K. Effects of facilitated tucking during 
routine care of infants born preterm. Pediatr Phys Ther 2005;17:158-63. 
44. Johnston CC, Stremler R, Horton L, Friedman A. Effect of repeated doses of sucrose during 
heel stick procedure in preterm neonates. Biol Neonate 1999c;75:160-6. 
45. Slater R, Cornelissen L, Fabrizi L, et al. Oral sucrose as an analgesic drug for procedural 
pain in newborn infants: a randomised controlled trial. Lancet 2010;376:1225-32. 
46. Lasky RE, van Drongelen W. Is sucrose an effective analgesic for newborn babies? Lancet 
2010;376:1201-3. 
47. Cignacco E, Axelin A, Stoffel L, Sellam G, Anand KJ, Engberg S. Facilitated tucking as a non-
pharmacological intervention for neonatal pain relief: is it clinically feasible? Acta Paediatr 
2010;99: 1763-5. 
 
  
 
 
CHAPTER IV 
 
FACILITATED TUCKING AS  
NON-PHARMACOLOGICAL INTERVENTION FOR 
NEONATAL PAIN RELIEF: 
IS IT CLINICALLY FEASIBLE? 
Cignacco EL, Axelin A, Stoffel L, Sellam G, Anand KJ, Engberg S 
 
 
 
 
Published in Acta Pediatrica 2010; 99: 1763-5  
FACILITATED TUCKING – COMMENTARY  
78 
 
 
 
ABSTRACT 
There is an impressive body of knowledge on pain management in infants hospitalized in 
neonatal intensive care units. However, deficits in the clinical management of pain in these 
infants remain. One reason is the gap between research evidence and translation of this 
knowledge into the clinical setting. This is particularly true for non-pharmacological pain 
relieving methods. Effective performance of some of these methods requires additional staffing 
and time. This viewpoint articles describes the clinical challenges associated with implementing 
facilitated tucking. Although facilitated tucking is described as an efficient method for acute pain 
relief, the clinical facilitators required to successfully implement such a resource consuming 
intervention remain unclear. 
Conclusion: Translational research on the feasibility of using facilitated tucking in the 
management of neonatal pain is warranted, including the economic impact of this intervention. 
Increased manpower costs need to be weighed against the possible long-term economic 
consequences of pain exposure in infants. 
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An increasing number of research studies are being performed to examine the 
effectiveness of non-pharmacological pain relieving interventions (NPIs) 1-6 for the treatment of 
infants exposed to acute painful events in the neonatal intensive care unit (NICU). As evidenced 
by several studies, preterm infants are experiencing a high number of routine skin breaking 
procedures associated with pain 7, 8, which may have a long-term impact on cognitive and 
behavioural outcomes 9. 
Pharmacological analgesia has well-known side effects and questionable impact on neonatal 
outcomes 10, 11. The drive to find suitable non-pharmacological alternatives is, therefore, highly 
commendable in the context of acute pain related to diagnostic and therapeutic procedures. This is 
particularly true for resource challenged countries.  
Recent reports on the impact of NPIs are usually limited to their effectiveness to reduce 
pain. There is no report describing their feasibility defined as the time, costs and ease of 
implementing these interventions in the clinical setting. In addition to such economical and 
organizational factors, the performance of non-pharmacological methods requires a paradigm of 
care which is highly patient and parent oriented, driven by empathy and focused attention. This 
focus may require a change in existing attitudes and values within a NICU-team, as this kind of 
interaction in patient care does not seem to be taken for granted 12.  
As an example, facilitated tucking (FT) was shown to be effective in the relief of acute 
neonatal pain 13-16. It is defined as containment of the infant’s arms and legs in a flexed, midline 
position close to the trunk. Depending on the painful intervention needed, different holding 
techniques are warranted. For suctioning procedures e.g. the close holding of infant’s arms and 
legs is recommended (see figure 1).   
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Figure1: Facilitated tucking position for suctioning procedure 
 
 
 
 
 
 
 
For the heel-stick one hand holds the infant’s trunk, while the other holds softly the head 
(see figure 2). The effective utilization of this intervention requires about 10 minutes of 
interaction with the infant in order to provide the infant with the sense of being held and 
attended to through the unpleasant experience of pain. FT should be started about 3 minutes 
prior to the painful procedure to help the infant adapt to the tactile stimuli of two adult hands 
holding him. Relaxation of the infant is generally observed after about 3 minutes of FT, so the 
painful procedure itself should not start until after the infant is relaxed. The same holds true for 
the post-procedural period: the FT needs to continue for at least 3 minutes to give the infant the 
opportunity to recover and return to baseline-status. FT requires an increase in manpower as 
two nurses are needed during the painful procedure: one to tuck the child and the other to 
perform the painful intervention. Given current financial restrictions and staff shortages in 
health care settings, the feasibility of implementing such a resource consuming intervention 
must therefore seriously be questioned 17.  
 
FACILITATED TUCKING – COMMENTARY 
81 
Figure 2: Facilitated tucking position for heel-stick procedure. 
 
 
 
 
 
 
 
This fact was shown in a current multi-site RCT testing the effectiveness of FT across 
repeated pain exposures of infants < 32 weeks of gestation 18. Within this RCT, the intervention 
was designed to be performed by nurses during their regular shift. This meant that two nurses 
involved in daily routine care were needed for the study intervention, one to perform the heel-
stick for blood sampling and the second to comfort the infant. These are the same personal 
resources that would be needed in a “real life” clinical situation of an NICU offering FT as a pain 
relieving method. Our experience within the mentioned RCT showed that the allocation of a 
second staff nurse to do the FT was difficult due to the work load during the shift. Nurses 
involved in the study questioned why an intervention was being tested for its effectiveness, if 
the personnel needed to use this method within routine clinical care is questionable. Another 
concern was that such research could provide nurses with new knowledge about an effective 
pain relieving intervention, but also burden them with the awareness that they are not to be able 
to perform this “good clinical practice” due to limitations in resources. These concerns 
expressed by dedicated nurses need to be taken seriously by the research community. Other 
NPIs like kangaroo care, swaddling, use of non-nutritive sucking and sucrose have evidence of 
efficacy 1-6 and are less resource consuming and may, therefore, be more feasible and practical 
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for care providers to utilize in clinical practice. However, in light of the increasing interest 
towards non-pharmacological pain relief in a NICU, the question of facilitators for successful 
implementation of these methods remains to be investigated in the future.  
Scientists should avoid accumulating evidence without exploring the clinical feasibility of 
implementing FT as a non-pharmacological intervention through translational research. The 
goal of translational research is to accelerate the movement of scientific findings into clinical 
practice and, thereby, improve health care outcomes for patients 19,20. Related to the pain 
relieving intervention of FT, translational research has the potential to close the gap between 
what we know from existing evidence related to its effectiveness 13-16 and what nurses really 
practice or are able to practice in the clinical setting under given economic circumstances. In the 
future FT must be tested in real practice NICU settings, which are characterized very often by 
uncontrolled and often uncontrollable conditions. Through translational research, scientist and 
clinicians can identify problems of utilization of this specific pain relieving intervention and 
collaboratively work on practical and setting-tailored solutions. One possible solution might be 
to enhance the parent’s involvement in the care of their infant by utilizing them do perform the 
FT as was already explored by our Finnish colleagues 15 or by engaging support personnel or 
individuals working as volunteers in the hospital. Translational research has the potential to 
provide a “win-win situation” not only for the infants and their families, but for research 
scientists and clinical personnel as well. Therefore, future translational research on the clinical 
feasibility of FT is warranted, including the economic impact of this intervention. In such a study 
the increased manpower costs need to be weighed against the possible long-term economic 
consequences of repeated and harmful pain exposure of preterm infants.  
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ABSTRACT 
Background: Major efforts to develop objective measurement tools for neonatal pain 
assessment have been made. However, the challenge of measuring pain in neonates remains 
suggesting that contextual factors (CFs) might alter their responses to pain. Although the role of 
CFs is increasingly discussed as crucial for pain assessment, they are not well described in the 
literature and are rarely considered in the clinical setting despite their importance.  
Aim: To systematically examine studies investigating the impact of CFs on pain response 
in preterm infants. 
Method: A literature search was undertaken for the period from 1990-2009. Studies 
reporting the relation between one or more CFs and pain response in preterm infants during a 
heel-stick procedure were considered for inclusion. 
Results: Twenty-three studies satisfied inclusion criteria. The studies varied relative to their 
design, sample, analysis procedures, and variables examined. Six categories of CFs emerged: age, 
pain exposure, health status, therapeutic interventions, behavioral status, and demographic factors. 
The examined CFs varied in the strength of their association with pain response, although none were 
invariably related, as evidenced by contradictory findings. In some cases the inconsistencies 
appeared attributable to methodological limitations in studies. Behavioral and physiological pain 
responses were not always in agreement as would be expected. 
Conclusion: This review supports the influence of some CFs on pain response. However, 
the results remain inconclusive which may be, in part, related to the heterogeneity of the studies. 
Contextual factors need further investigation for a better understanding of the magnitude of 
their effect on pain response.   
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5.1 INTRODUCTION 
Due to new reproductive technologies and advancing maternal age, preterm birth rates 
continue to rise in many industrialized countries 1,2. To ensure survival preterm infants need 
neonatal intensive care (NICU), which is associated with high procedural pain exposure 3,4. The 
developing nervous system undergoes extensive changes postnatal 5 and repeated exposure to 
pain early in life may lead to significant changes in pain processing while the infant remain in NICU 
6-9 and to altered pain response later in infancy 6,10,11 and later in life 12,13. 
The challenges of assessing pain in neonates are recognized, and major efforts have been 
devoted to the development of measurement tools for neonatal pain 14. Despite these major 
commitments, it is also recognized that the neonatal response to pain is influenced by more than 
the invasive procedure itself, and contextual influences must be considered in the evaluation of 
pain.  
The impact of immediate contextual factors (CFs) as determinants of the high variability in 
pain responses of preterms also contributes to complicating their pain assessment. Cignacco et al. 
15 described higher within than between subject variability in pain responses among preterms 
across 5 heel-sticks during a 14-day period. The inter-rater agreement in pain assessment was 
high for the 3 first heel-sticks and lower for later heel-sticks, suggesting that there may be 
alterations in preterms’ pain response across time. This variability could be due to a combination 
of low gestational age (GA) and high pain exposure, which provokes changes in response over time 
16 with an impaired level of response sensitivity as post-natal age increases 17,18.   
Craig and Pillai Riddell 19 provide a basis for conceptualizing the importance of CFs. In 
their model pain should be viewed as a dynamic and interactive process between infant’s pain 
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response and the caregiver. The model examines three central features: painful event, child, and 
caregiver. The influence of familial, community and cultural environments is recognized as well. 
When focusing on preterm infants in the NICU, immediate medical and demographic factors 
appear to have a more direct influence on pain experience and expression than cultural and 
community factors. In our formulation of the model (Figure 1), we provide a focus on medical 
and demographic CFs influencing pain by putting the health care team next to the preterm infant 
within those circles of environments that influence pain.  
Although the role of CFs is increasingly discussed as crucial, they are not well described in 
the literature and rarely considered in pain assessment. There are no published systematic 
reviews of the impact of CFs on pain response in preterm infants. The aim of this study was to 
systematically review existing literature examining the relationship between CFs and pain 
response in preterm infants. 
Figure 1: The Socio Communication Model of Infant Pain – Modified Model 
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 5.2 METHODS 
This systematic review is reported according to the present PRISMA guidelines (Preferred 
Reporting Items for Systematic reviews and Meta-Analyses) 20. Searches were undertaken in the 
following databases: Medline, Cochrane library, CINAHL, Web of Science, and PsycInfo covering 
the period from 1990 to November 2009. Our search was restricted to studies published in 
English and with human subjects. In PubMed and Cochrane, the MeSH headings “Infant, 
Premature” and “Pain” were entered in combination with the following searching terms: 
“response”, “response AND heel-stick”, “response AND contextual factors”, “response AND 
determinants”, “response AND confounders”, “response AND contextual indicators”, “response 
AND risk factors”, “response AND predictors”, “response AND gestational age”, “response AND 
severity of illness”, “response AND co-morbidities”, “response AND neurological impairment”, 
“response AND analgesics”, “response AND medications”, “response AND number of painful 
procedures”, “response AND time from last painful procedure”. The same search was performed 
with the search terms “expression” and “reaction” instead of “response”. In databases without 
MeSH possibilities the search terms “preterm infants” and “pain” were combined consistently 
with the search terms “response”, “expression”, “reaction” and the other combined search terms. 
The databased systematic search for studies including CFs was challenging, as few studies 
referred exclusively to them. Contextual factors are rather “lurking” variables in the 
measurement of pain in neonates. We, therefore, used the ‘snowball method’ also looking for 
references in the most recent publications relating to CFs. Two of the authors (SE and GS) 
evaluated the papers independently for eligibility according to the inclusion criteria. In the case 
of disagreement between the two reviewers, a third author (EC) participated in the evaluation 
process. After discussion a decision was made about inclusion of the study. 
  
CONTEXTUAL FACTORS -SYSTERMATIC REVIEW 
90 
5.2.1 Selection process 
The systematic search of the 5 databases returned 2,289 citations while an additional 39 
studies were identified when the references of recent publications were hand searched. After 
deleting duplicate articles, 991 were screened by title or abstract for relevance.  Based on this 
review, 91 articles were retrieved for detailed review based on the inclusion criteria (see Table 1 
and Figure 2). A total of 23 studies met the selection criteria and were included in this review. 
Studies examining the association between CFs and pain responses in preterm infants (up to 37 
weeks of gestation) hospitalized in a NICU were included regardless of the study design. Heel-
stick procedure was chosen as a representative painful procedure as it was a focus of many of 
the studies, it is one of the most common painful procedures performed in the NICU setting and 
it is performed internationally using similar methods.   
Table 1: Inclusion criteria 
Inclusion Criteria 
1. Published as peer-reviewed article in English. 
2. Reported neonatal subjects ventilated or not ventilated infants. 
3. Examined heel-stick procedure as painful intervention. 
4. Examined the relationship between one or more CFs and pain responses.  
5. Relied on a validated pain assessment tool. 
6. All possible research study designs were considered.   
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Figure 2: Flow diagram of study selection process (PRISMA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.2 Quality assessment process of the included studies 
We were unable to identify a standardized instrument designed to assess the quality of studies 
examining factors associated with a particular outcome. Consequently, we adapted a quality criteria 
checklist used in a prior systematic review examining fall risk factors 21. The checklist contains 12 
dichotomous questions (Table 2). The 23 selected studies were evaluated independently by three of 
the authors (GS, ES and EC). In case of disagreement, a discussion took place until consensus was 
reached. No studies were excluded on the basis of the quality assessment. 
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Table 2: Quality Assessment 
  REFERENCE 1A 1B 2 3A 3B 3C 3D 4A 4B 4C 5A 5B 
1 CRAIG ET AL_1993 Y Y Y Y Y Y Y Y Y Y Y Y 
2 EVANS ET AL_2005 Y Y Y Y Y Y Y Y Y Y Y Y 
3 GIBBINS ET AL_2003 Y Y Y Y Y Y Y N N Y Y Y 
4 GIBBINS ET AL_2008_I Y Y Y Y Y Y Y Y Y Y Y N 
5 GIBBINS ET AL_2008_II Y Y Y Y Y Y Y Y Y Y Y N 
6 GRUNAU ET AL_2001_I Y Y Y Y N Y Y Y Y Y Y Y 
7 GRUNAU ET AL_2004 Y Y Y Y Y Y Y Y Y Y Y N 
8 GRUNAU ET AL_2005 Y Y Y Y Y Y Y Y Y Y Y Y 
9 HOLSTI ET AL_2006 Y Y Y Y Y Y Y Y Y Y Y Y 
10 JOHNSTON & STEVENS_1996 Y Y Y Y Y Y Y Y Y Y Y Y 
11 JOHNSTON ET AL_1995 Y Y Y Y Y Y Y Y Y Y Y Y 
12 JOHNSTON ET AL_1996 Y Y Y Y N N Y Y Y Y Y Y 
13 JOHNSTON ET AL_1999 Y Y Y Y Y Y Y Y Y Y Y Y 
14 MORISON ET AL_2003 Y Y Y Y N Y Y Y Y Y Y N 
15 OBERLANDER ET AL_2002 Y Y Y Y Y Y Y Y Y Y Y Y 
16 PORTER ET AL_1998 N Y Y Y Y N Y Y Y Y Y Y 
17 SLATER ET AL_2009 Y Y Y N Y Y Y Y Y Y Y Y 
18 STEVENS ET AL_1994 Y Y Y Y Y Y Y Y Y Y Y Y 
19 STEVENS ET AL_1999 Y Y Y Y Y Y Y Y Y Y Y Y 
20 WALDEN ET AL_2001 Y Y Y Y N N Y Y Y Y Y Y 
21 WARNER_2001  Y Y Y Y N Y Y Y Y Y Y Y 
22 WILLIAMS ET AL_2009 Y N Y Y N Y Y Y Y Y Y Y 
23 XIA ET AL_2002 Y Y Y Y Y ? N N N Y Y N 
Legend: Criteria for quality assessment of the included papers 
1A, Definition of preterm infants; 1B, Definition of CF; 2, Description of study period-how many HS; 3a, 
Definition of criteria for inclusion and exclusion; 3B, Sample size based on power analysis or > 20 per predictor; 3C, 
Drop out less than 20%; 3d, Specification of sample characteristic; 4A, Adequate description of primary data 
collection or procedure of secondary data analysis; 4B, Data collection by standardized procedures; 4C, Used a 
validated pain assessment tool; 5a, Reported relationship between CF and pain statistically; 5b, Using methods of 
multivariate analysis (Multivariate analysis was defined as: Analysis that controlled for the effects of one or more 
confounding variables or covariates).  
Y=yes (in agreement); N=no (in agreement); ?= not specified. 
5.3 RESULTS 
5.3.1 Study characteristics  
The systematic search revealed studies that examined the association between the following 
CFs and pain response: (1) age related CFs [GA, post-natal age(PNA), post-conceptual age]; (2) 
pain exposure related CFs (time since last painful procedure, total number of previous painful 
procedures or the number within the 24 hours prior to the heel-stick procedure); (3) health status 
related CFs (severity of illness, neurological impairment and other co-morbidities, Apgar scores, 
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length of stay in NICU); (4) therapeutic intervention-related CFs (administration of medications 
such as opioids, mechanical ventilation, handling before the heel-stick, and positioning); (5) 
behavioral CFs (sleep state prior to the heel-stick procedure, temperament of the infant); and (6) 
demographic factors (race, gender, and weight). The included studies were of various designs. 
However they could be allocated to either the category of observational studies (78%, n=18) or 
interventional studies (22%, n=5) (Table 3). All included preterm infants in their study population, 
with 78% (n=18) examining preterm infants exclusively and 22% including term infants as a 
control group (n=5). Most studies excluded infants at risk for neurological impairment (91%, 
n=21). All of them assessed pain during a heel-stick procedure, either for single (74%, n=17) or 
repeated (26%, n=6) heel-sticks. Pain response was assessed with different behavioral and 
physiological assessment instruments, which were described as reliable and valid. The studies 
using physiological measures examined heart rate and oxygen saturation as pain indicators. The 
majority of studies used one of two behavioral instruments used for pain measurement: the 
Premature Infant Pain Profile (PIPP) and the Neonatal Facial Coding System (NFCS). Thirty 
percent of the studies (n=7) used the PIPP, and 65% used the NFCS (n=15). One study only used 
the Neonatal Infant Pain Scale (NIPS). Most of the studies examined behavioral outcomes 
separately from physiological outcomes. Ninety-one percent of the studies (n=21) examined both 
physiological and behavioral outcome measures, while 7% (n=2) only reported findings related to 
behavioral outcomes. Of the 21 studies that examined both physiological and behavioral outcomes, 
74% (n=17) examined the outcomes separately while 17% (n=4) examined them in combination. 
Most of the studies reported a total score on the outcome measures (61%, n=14), while the 
remaining studies reported findings on the specific behavior/physiologic components assessed by 
the measurement tool. In the quality assessment, ten studies met all the quality criteria 16,17,22-29. All 
the studies met the following criteria: description of study period, reporting how many heel-sticks 
were performed (2); use of a validated pain assessment tool (4c); and reporting the relationship 
between CFs and pain statistically (5a) (Table 2). Six studies did not report that their sample size 
was based on a power analysis or did not include > 20 subjects per CF examined (criteria 3b) 18,30-
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35, while five did not examine the relationship between the CF and pain responses multivariately 
(5b) 31,36-39 and four had a drop-out rate of > 20% (3c) 18,32,33,39. With the exception of one study 39 
which failed to meet 5 criteria, the rest of the studies met all but one or two criteria. 
 5.3.2.1 Age-related contextual factors 
While infant age was the most commonly examined CF, it was measured in a variety of 
ways. In addition, the terminology utilized to describe age varied. Information presented in the 
articles indicated age was classified as (1) GA, the age of the infant at birth; (2) PNA, the age of 
the child at the time of the heel-stick, i.e. days since birth; and (3) post-conceptual age, the sum 
of the age at birth + age since birth.  
Gestational age was the most commonly examined CF. Eleven studies (48%) examined GA 
as a CF influencing behavioral pain responses 16,17,24,26,30,31,34,36,37,39,40 with eight of these 
examining physiological response as well 16,17,24,26,31,36,37,39. Five studies reported a statistically 
significant GA effect on behavioral response to pain with greater behavioral response as GA 
increased 17,24,30,37,39. Four studies reported that GA was unrelated to behavioral responses to 
pain 16,26,34,36. Three of the eight studies examining the impact of GA on physiologic responses 
reported a significant effect of GA on oxygen saturation and/or heart rate 17,30,37. Gibbins et al. 37 
reported that GA had a significant effect on oxygen saturation but not on heart rate while Craig 
and colleagues 17 reported that there was a significant GA effect on heart rate but not on oxygen 
saturation. While there was a negative correlation between GA and heart rate variability in the 
study of Morison et al. 31 (r = -0.64), the correlation between GA and post-lance heart rate was 
weak (r = 0.16). Most of the studies examining the effect of GA on physiological response did not 
find any significant effect on heart rate or oxygen saturation 16,24,26,31,36,39. Four studies measured 
pain with the PIPP, which included behavioral and physiological parameters. Three reported a 
significant GA effect on the total PIPP score 22,25,41, while one described a non-significant effect 29.  
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Post-natal age (PNA) was examined by 5 studies16,18,25,29,34. All three studies that examined 
the impact of PNA on behavioral outcome measures reported a significant relationship with 
vigor increasing with PNA 18,25,34. Two studies examined the impact of PNA on total PIPP scores 
and neither found a significant effect during multivariate analysis 25,29. Two studies examined the 
impact of post conceptual age on pain responses 33,40. One of these studies reported that post 
conceptual age was significantly positively related to 'time to facial response' during heel-stick 
and that infants with no responses had significantly lower post conceptual ages than those with 
facial responses 40. The other study 33 reported that post conceptual age was not significantly 
related to facial responses (eye squeeze or brow bulge), total PIPP scores, heart rate or oxygen 
saturation. In this study, the only behavioral response that showed a significant post conceptual 
age effect was finger splay with significantly fewer younger infants showing a response 
compared to older infants. 
 5.3.2.2 Previous pain exposure- related contextual factors 
Investigators have examined the relationship between (1) previous number of painful 
procedures, (2) the time since the last painful procedure and (3) the number of painful 
procedures during the 24 hours prior to the heel-stick. The number of prior painful procedures 
was examined in eight studies 16,18,22,23,25,29-31. Three studies 16,30,31 reported that the total number 
of previous painful procedures was significantly inversely related to behavioral pain responses 
and two described a significant positive association with total PIPP scores 22,29. In contrast, two 
studies reported that there was no significant relationship between the number of previous 
painful procedures and behavioral responses to pain 18,23 and one did not find a significant 
relationship with PIPP scores 25. Five studies examined the relationship between the number of 
prior painful procedures and heart rate 16,18,23,30,31. Three reported that the relationship was not 
significant 16,18,23 while one study found that the number of previous painful procedures was 
significantly related to heart rate variability 30 and another reported a moderate but non-
significant correlation with heart rate (r = 0.40) 31. Two studies examined the relationship 
between the number of previous painful procedures and oxygen saturation and the relationship 
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was not statistically significant in either study 16,18. One study concentrated on the time since the 
last painful procedure and found a non-significant negative relationship to PIPP scores 25. Two 
studies examined the relationship between painful procedures during the previous 24 hours and 
pain response 31,34 but found no significant relationship.  
 5.3.2.3 Health status-related contextual factors 
A number of studies examined the association between health status variables (severity of 
illness, neurologic impairment, sepsis, Apgar scores and length of stay in the NICU) and preterm 
infants' pain responses. Seven studies examined severity of illness 16,18,22,28-31. Four studies found 
no significant associations between severity of illness and behavioral and/or physiologic pain 
responses 16,18,29-31. In one study 28, findings were mixed with a significant effect on cry variables 
but no significant relationship to NFCS scores was found. Only one study reported that severity of 
illness was significantly related to pain scores. Evans et al. 22 reported that there was small but 
significant negative association between severity of illness and PIPP scores.  
The influence of neurological impairment on pain response was examined in three studies 
27,34,40. While neurologic impairment was not related to most of the measures of pain response in 
these studies, it was significantly related to tongue protrusion in one study 27. One study 
examined the association between sepsis and pain responses 34 and found no significant 
relationship. Apgar scores at 5 min. were examined in 5 studies 16,25,30,31,34. In three of the studies, 
Apgar scores were not significantly related to pain responses 25,30,34. In contrast, Johnson and 
Stevens 16 reported that 5-minute Apgar scores were significantly inversely related to brow 
bulge and nasolabial furrow scores but not to eye squeeze, heart rate or oxygen saturation, while 
Morison et al. 31 described a significant positive correlation between 1-minute Apgar scores and 
total facial responses during the heel lance (r = 0.80) and non-significant correlations with eye 
squeeze scores during heel lance and post-lance heart rate as well as a non-significant 
correlation with stress cues. In the study of Morison et al. 31 stress cues were measured by the 
Neonatal Individualized Developmental Care Assessment (NIDCAP). The purpose of NIDCAP is 
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to assess - according to a comprehensive set of body movements - the stability or the state of 
stress the premature infant expresses. Care based on NIDCAP aims at enhancing infant’s stability 
throughout a highly individualized care. The observed stress cues were tremor, startle, twitch, 
extended arms/legs, diffused squirm, arch, fisting, finger splay, airplane, salute, sitting on air, 
stretch/drown, and flaccid arms/legs. 
Length of stay in NICU was examined by one study and was not significantly related to 
pain response 34.  
 5.3.2.4 Therapeutic interventions- related contextual factors 
Relationship between selected interventions and pain responses were examined. These 
interventions were medications, mechanical ventilation, handling, and positioning. Preterm 
infants in the NICU receive a wide range of medication. Medications reported in the literature 
were mainly opioids, steroids, and caffeine. Three studies examined the relationship between 
infants receiving analgesics during the time of the study and pain responses 23,30,40. In one study, 
receiving morphine prior to the heel-stick was significantly positively related to latency of facial 
expression 40. In the second study, total morphine administration was negatively related to heart 
rate variability but was not significantly related to pain behaviors 30. The latter study reported 
that total days of dexamethasone was negatively related to the pain behaviors and positively 
related to heart rate variability. One study examined caffeine and found no significant 
relationship to pain response 25. 
Other therapeutic interventions were investigated in a smaller number of studies. 
Mechanical ventilation was examined in three studies 18,30,34. None of the studies found a significant 
relationship between ventilator status and pain response. Two studies examined handling of the 
infant prior to the heel-sticks procedures and found significant negative effects on behavioral 
responses to pain 24,32. One of the studies 32 also reported a significant effect on heart rate, while 
other 24 did not. Another one compared pain responses in infants in prone and supine position 
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prior to their heel-stick and found no significant interaction between positioning and the phase of 
the heel-stick for total facial activity, heart rate or sleep/wake state 38.  
 5.3.2.5 Behavioral contextual factors 
The relationships between behavioral factors (sleep-wake cycle and temperament) and 
pain responses were examined in three studies 25,35,40. Two studies described sleep/wake state 
as a predictor for pain response 25,40. In one of the studies 40 sleep/wake state was positively 
significantly related to NFCS scores (meaning the more alert the infant the less the response), 
but not to changes in facial expression measured by the PIPP or to cry variables. In the other 
study, sleep/wake state was not significantly related to PIPP scores 25. 
Temperament was examined by Warner 35. While there was no significant relationship 
between mother’s perceptions of their infant’s pre or post-natal activity levels, there were 
significant relationships between temperament and pain response as measured by some items 
of the NIDCAP and PIPP scores. In this study, temperament was operationalized by high or low 
motor reactivity, high or low motor intensity, and high or low threshold. Infants who were 
higher reactivity responders based on the NIDCAP had significantly higher PIPP scores than 
those who were lower reactivity responders. The relationships to heart rate and oxygen 
saturation were non-significant. 
 5.3.2.6 Demographic factors 
Demographic factors, specifically weight 16,30,31,34, race 25,34, and gender 18,24,25,34 were 
examined in several studies. Two of the studies describing the relationship between infant 
weight and pain responses reported that the relationships were not significant 30,34. In contrast, 
Johnson and Stevens 16 reported that there was a significant negative relationship between birth 
weight and oxygen saturation response to the heel-stick. Birth weight was not significantly 
related to any of the other pain response variables measured in this study (brow bulge, eye 
squeeze, nasolabial furrow or heart rate). Morison and colleagues 31 reported that birth weight 
was significantly negatively correlated with total facial responses (r = -0.61) and with stress 
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cues (r = -0.73). In addition, there were non-significant correlations between birth weight, eye 
squeeze scores, and heart rate variability. Investigators found that there was no significant 
relationship between race 25,34 or gender 18,24,25,34 and pain responses.  
5.4 DISCUSSION 
The systematic review provided insight into the influence of CFs on preterm infant’s pain 
response during heel-stick procedures. Certain CFs exerted substantial effects. Other findings 
suggested subtle, inconsistent and probably not clinically important impact. Many of the findings 
were inconclusive and deserving of studies with more methodological rigor. 
Age - The most commonly examined CFs group, age, was the CF that most consistently 
affected pain responses in these studies. The results showed that facial expression response to 
pain tended to increase with age. This effect can be explained by the development of the nervous 
system. The cephalocaudal development of facial musculature may influence the magnitude of 
facial activity as evidenced by the fact that preterm infants have less muscular strength, posture, 
tone and body movement compared to term infants 31,36,41. Moreover, preterm infants are 
significantly more hypotonic than term infants with smooth movements improving as PNA 
increases 18. Most of the studies (57%) that examined the relationship between GA and facial 
responses or PIPP scores (which include assessment of facial responses) during heel-sticks 
reported statistically significant relationships, while 42% of the studies did not find a significant 
relationship between GA and pain expression. These findings could be explained by limitations 
of studies. Gibbins et al. 36 explored physiological and behavioral pain response; however, they 
included only infants with extremely low GA (23-25 6/7; 26-28 weeks). They found no 
differences in pain response between the two groups. Both groups showed more total facial 
expression at the lance phase compared to baseline. It is noteworthy that facial expression is a 
behavioral response to pain seen with even the earliest viable newborn infant, attesting to its 
inherent biological nature. Stevens et al. 29 also reported a non-significant relationship between 
GA and pain responses. Similar to Gibbins et al. 36 they examined only extremely low GA infants. 
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The studies finding a significant effect of GA included infants born at term or a group of infants 
greater than 28 weeks GA. Three of the studies with non-significant results 16,29,34 did a 
multivariate analysis and examined PNA as well as GA. Two of them found significant relation to 
PNA. By incorporating post-natal age into the analysis, the effect of GA may be reduced or not 
valid any longer.  
Previous pain exposure - Most of the studies examining the impact of number of prior 
painful procedures reported a positive significant relationship with pain response, meaning that 
higher numbers of painful procedures were related to a lower behavioral pain response. 
Reduced pain expression based on the number of painful procedures has a variety of 
explanations. Infants with a very low GA (24-28 weeks) were found to have a higher procedural 
exposure due to their general immaturity and need for a higher degree of intensive care and 
their length of stay in the NICU 15. However, the only study examining length of stay in the NICU 
did not find that it was significantly related to pain responses. The blunted pain responses, 
mainly reported in relation to facial activity, in very preterm neonates may also be a sign of 
exhaustion as a result of all of the procedures and handling they experienced during 
hospitalization in the NICU 25,32. Logically, these explanations could be related to the GA of the 
infant. The proximity to the last painful procedure might explain variation in pain response as 
well 25. A further possible explanation for low responsiveness is the endogenous production of 
endorphins in response to the last procedure, which might have protected the infant from the 
pain resulting from the subsequent procedure 25. However, the validity of this explanation may 
be limited depending on the time from the last painful procedure. Only one study examined the 
relationship between the time since the last painful procedure and pain responses and the 
relationship was not significant.   
Health status - Most of the studies that examined the relationship between health status 
and pain responses did not find significant relationships. In the three studies examining the 
relationship between neurological impairment and pain responses, there was no significant 
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relationship. It seems possible that the biological substrates for pain are not that readily affected 
by the health status of the infant. An explanation for these findings is that during this period of 
immaturity, the brain injury has not yet expressed and that identifiable differences in pain 
response and functional impairment might only be observed at a later age 27.  
Therapeutic interventions - Although preterm infants in the NICU usually receive 
medications, their impact was examined in only a very small number of studies. Scott et al. 42 
reported that morphine reduced facial activity associated with heel-stick. However, the present 
review found contradictory findings regarding the influence of morphine on pain expression 
23,30,40. Preterm infants who are critically ill and undergoing mechanical ventilation typically 
receive continuous fentanyl infusion or other sedatives. Some pharmacological sedation 
interventions may also dampened pain experience and/or pain expression 43. None of the 
studies examining mechanical ventilation found a relationship with pain response. In one of 
these studies, dexamethasone administration was negatively related to NFCS scores and 
positively related to heart rate 30. These results were interesting and should be examined in 
future studies. As preterm infants in a NICU setting are being expose constantly to various 
medications, further research on this topic is required.  
Behavioral state - Temperament, measured by the NIDCAP, was significantly positively 
related to the PIPP scores in one study 35. Although the findings of Warner are interesting, they 
need to be interpreted cautiously, as temperament was only examined with the NIDCAP, which 
is a developmental assessment and not a valid tool for the assessment of temperament.  
Sleep/wake state was positively significantly related to NFCS scores 40 but not to changes 
in facial expression measured by the PIPP 25,40. The positive relation between the sleep/wake 
state and NFCS scores is supported by two additional studies which were not included in the 
present systematic review because they did not meet our inclusion criteria. Slater et al. 44 
reported typical cortical pain response (measured by near infrared spectroscopy) to heel-stick 
in infants between 25-45 weeks of gestation. The responses were significantly greater in awake 
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compared to sleeping infants. Grunau and Craig 45 reported, that awake infants responded with 
significantly more facial movement compared to infants who were asleep. These studies suggest 
that sleep/wake state is an important factor in pain response and support the need for more 
research to confirm these relationships.   
5.4.1 Limitations 
There are some methodological shortcomings that need to be taken into account when 
considering the findings of this review. The CFs were not always defined or measured in the 
same manner. The age of the infants included in the studies varied as did the time point of first 
data collection after birth. The number of studies examining some of the CFs was quite small. 
Due to all of these limitations, a meta-analysis was not possible. 
Furthermore, most of the studies measured facial activity as the pain indices. In the 
majority of studies, the NFCS and the PIPP were used as pain assessment tools. Both of the tools 
focus mainly on facial activity without including body movements. Yet, body movements are a 
major indicator of pain, which can be observed at the earliest GA and could also be sensitive to 
the influence of CFs. 
5.5 CONCLUSIONS 
The results suggest that contextual factors play an important role in preterm infants’ 
responses to pain and should be considered when pain is measured. However, there was 
variable impact, with none of the CFs examined consistently related to pain response, and 
there was an inconsistency between behavioral and physiological responses to pain. One of the 
issues in interpreting these findings across studies was the inconsistencies in the 
characteristics of the samples and designs. Our understanding of the role of CFs will be 
advanced by well-designed prospective studies that use consistent definitions of CFs such as 
GA and the neonatal groups’ ages being compared and an adequate sample  of extremely low 
and low GA infants. We acknowledge that one of the challenges of examining the effects of 
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various CFs on pain response is that there is a high degree of correlation between factors.  
Consequently, it is challenging to disentangle the effect of any single factor on pain response. 
Due to this interrelationship, the ideal study would need to be adequately powered to allow a 
multivariate study of all the CFs identified in this review as potentially influencing pain 
responses. One of the strengths of the studies that have been done is that they used reliable 
and validated pain measures. Since there is evidence, however, to suggest that CFs may have a 
differential effect on behavioral and physiologic pain responses, future studies should examine 
them separately. Studies should report the magnitude of the effect of these factors on pain 
responses in this population. Once we better understand the factors that influence neonatal 
pain responses, neonatal pain assessment instruments have to be revised in order to 
determine whether a preterm neonate is in pain or not. 
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Table 3: Studies examining Contextual Factors and pain response in preterm infants 
 
Nr Study Design/Settings/Sample Variables 
Measurement of 
primary outcomes 
Findings 
1 Craig et al 
1993  
(Canada)  
Design: Cross sectional. 
Settings: Special care nursery. 
Sample: n=56, 5 groups of GA wks: 
(1) 25-27, n=8;  
(2) 28-30, n=15; (3) 31-33, n=16; 
(4) 34-36, n=10;  
(5) 37-41, n=7.  
Mean Postnatal age (PNA)-total 
sample: ~4days. 
Ventilated at observation: n=3. 
 
No infants with neurological 
impairment (NI) were included.  
CFs: 
Gestational 
age (GA) 
Outcome: 
Responses 
across 
phases of the 
heel-stick 
(HS) 
procedure 
(baseline, 
swab, lance 
and 
recovery). 
Neonatal Facial 
Coding System 
(NFCS) 
 
 
 
Infant Body Coding 
System (IBCS) 
 
 
 
Heart rate (HR) 
 
 
 
Oxygen saturation 
(SaO2) 
Significant main effects for GA (F[4,51]=7.22, p<0.0001) and phase 
(F [3,153]=58.44, p<0.00001) as well as significant interaction 
between GA and heel-stick phase (F[12,153]=3.91, p<0.00001). No 
significant differences across phases for group 1; there were 
significant differences for the other four groups (p<0.0002 for group 
2 and <0.00001 for groups 3, 4 and 5).  
Significant main effects for gestational age group (F[4, 51]= 4.34, 
p<0.004) and for the procedure phase (F[3, 153]=47.71, p<0.00001).  
No significant interaction between gestational age group and 
procedure phase (p=0.65).  Infants at all gestational ages reacted to 
the swab and appeared to react more to the heel-stick. 
A significant phase effect (p<0.00001) and a significant GA group by 
procedure phase effect (F[16, 204]=3.14, p=<0.0001).  No significant 
different in HR across phases in group 1; significant differences 
across the phases in the other four GA groups (p<0.001 - <0.00001).  
SaO2 levels were not significantly different among the GA groups. 
Significant phase effect (F [4, 180]=6.80, p<0.00001) but no 
significant GA by phase effect. 
2 Evans et al, 
2005  
(USA)  
Design: Comparative longitudinal 
cross sectional. 
Settings: Regional level III NICU. 
Sample: n=81, 4 groups of GA: (1) 
<28; (2) 28-30; (3) 31-33; and (4) 
34-36 wks. 
PNA: < 72 hours since birth. 
Proportion of ventilated infants was 
not reported.  
No infants with NI were included. 
CFs: GA, 
severity of 
illness, 
number of 
painful 
procedures. 
Outcome: 
Pain 
response 
during 1-12 
HSs per 
infant 
Premature Infant 
Pain Profile (PIPP)  
 
 
Infants from group 3 had significantly higher PIPP scores (M=10.5; 
SD=3.7) than all other groups (group 1: M=9.8, SD=3.1; group 2: 
M=7.7, SD=2.3; group 4: M=9, SD=9.0) (p<0.02). 
Both severity of illness and the number of prior painful procedures 
were significantly related to PIPP scores (F[2, 305]=3.83, p=0.023). 
 
When considered together, there was a small but significant negative 
association between PIPP scores and NTISS scores and total prior 
painful procedures (p<0.047) [the more severe the infants condition 
&\or more painful procedures experienced prior to the HS, the lower 
the PIPP scores]. 
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3 Gibbins & Stevens, 
2003  
(Canada) 
Design:  Secondary data analysis of a 
RCT. 
Settings: NICU. 
Sample: n=190, 3 groups of GA: (1) 
27-31 6/7 wks, n=63; (2) 32-30 wks; 
(3) 32-35 6/7 wks, n=63; (4) 36-43 
wks, n=64. 
PNA: <7 days since birth. 
 
Proportion of ventilated infants was 
not reported. 
Infants with NI were excluded. 
CF: GA. 
Outcome: 
Pain response 
during 
one heel-stick. 
PIPP pain 
indicators 
 
 
 
 
 
 
 
 
 
HR & SaO2 
Significant GA differences were found in percentage of change from 
baseline in: 
• Brow bulge during the heel lance (F[187,2]=25.83, p<0.001) and 
heel squeeze (F[187,2]=18.47, p<0.001), 
• Eye squeeze during the heel lance (F[187, 2]=32.13, p<0.001) and 
squeeze (F[187,2]=29.84, p=0.01), and 
• Nasolabial furrow during the heel lance (F[187,2]=12.31, p=0.01) 
and squeeze  (F[187,2]=12.84, p=0.01). 
The most mature neonates showed the most facial activity while the 
least mature showed little facial activity.  
Significant GA differences in percentage of change from baseline in 
SaO2 during the heel lance (F[187, 2]=5.55, p=0.005) and squeeze 
(F[187, 2]=35.8, p=0.001) and in HR during the lance (F[187, 2]=70.79, 
p<0.001)and squeeze phases (F[187, 2]=35.8, p<0.001) with the least 
mature neonates having the least amount of change from baseline. 
4 Gibbins et al 
2008_I  
(Canada)  
Design: Secondary data analysis of 
data collected in two studies. 
Settings: NICU. 
Sample: n=161infants at varying risk 
for neurological impairment. GA in 4 
strata: (1) 23-27 6/7 wks (n=41); (2) 
28-31 6/7wks (n=50); (3) 32-35 
6/7wks (n=21); (4) >36wks (n=49).   
PNA: Not reported. 
Proportion of ventilated infants was 
not reported.  
CF: GA 
Outcome: 
Pain response 
during  
one HS. 
NFCS 
 
 
 
SaO2 
 
 
 
HR 
Differences in total facial activities from baseline to lance phase 
indicated significant differences (F[3, 145]=6.5, p<0.001) based on GA 
with the least mature infants having significantly less  change from 
baseline to lance compared to the 3rd and 4th strata. 
Significant differences in mean SaO2 between baseline and heel lance 
based on GA (F[3, 145]=3.1, p<0.03) with the greatest change seen in 
strata 2 and the least in strata 3. 
No significant differences in mean heart rate change from baseline to 
heel lance based on GA. 
5 Gibbins et al, 
2008_II  
(Canada) 
Design: Prospective descriptive 
crossover design. 
Settings: Major regional level III NICU.  
Sample: n=53 in two GA strata: (1) 
23-25 6/7wks (n=23 and (2) 26-
28wks (n=30). 
PNA: <7 days 
Proportion of ventilated infants was 
not reported.  
No infants with NI were included.  
CF: GA. 
Outcome: 
Pain response 
during one HS 
and a diaper 
change. 
NFCS 
 
Body movement 
 
 
HR 
 
 
SaO2 
No significant differences between the 2 GA in total facial activity.  
 
No significant differences in total body movements were between the 2 
GA groups. 
 
No significant GA effect. 
 
 
No significant GA effect. 
  
N
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6 Grunau et al 
2001  
(Canada) 
Design: Prospective cohort study. 
Settings: Level III NICU.  
Sample: n=136. GA 23.6-32.7 wks, 
mean = 28.1wks. 
PCA(GA+PNA): 32 wks. 
Proportion of ventilated infants was 
not reported (mean number of days 
was reported). 
No infants with NI were included.  
CFs: GA, birth 
weight, 5 
minute Apgar, 
mechanical 
ventilation, 
number of 
surgeries, 
severity of 
illness, number 
of painful 
procedures, 
medications 
exposure 
(morphine, 
dexa-
methasone, 
indomethacin, 
fentanyl and 
pancuronium). 
Outcome: Pain 
behavior and 
HR variability 
(HRV) based 
on the lance 
and squeeze 
phases during 
one HS. 
Pain Behavior 
=(0.73*NFCSlance) 
+(0.87*NFCSsqueeze) 
+(0.79*state)  
+(-0.19*ΔLF power) 
 
HRV 
=(0.31*NFCSlance) 
+(0.07*NFCSsqueeze) 
+(-0.13*state) 
+(-0.95*ΔLF power) 
In a regression analysis- GA (β=-0.60, p<0.0001), number of pain 
procedures (β=-0.51, p<0.0001)) and number of days on 
dexamethasone (β=-0.28, p<0.05) were predictors of pain behaviors. 
 
 
 
GA (β=0.56, p<0.0001), number of painful procedures (β=0.75, 
p<0.0001)), number of days on dexamethasone (β=0.43, p<0.01) and 
total morphine exposure (β=-0.20, p<0.05) were predictors of heart 
rate variability. 
7 Grunau et al 
2004 
(Canada) 
Design: Comparison study. 
Settings: Level III NICU.  
Sample:: n=38. GA-25-32 wks.   
PCA: 32 wks 
 
Proportion of ventilated infants was 
not reported (mean number of days 
was reported). 
No infants with NI were included.  
CF: Prone 
position.  
Outcome: Pain 
response 
during one HS. 
NFCS 
 
 
 
 
 
HR 
 
 
 
Sleep/wake state 
Significant increase in total facial activity from baseline to heel lance 
in both the supine and prone group (F[1, 36]= 68.32, p=0.0001) but 
no statistically significant main effect for position (F[1, 36]= 0.88, 
p=0.35) and no significant interaction between the phase of the heel-
stick and position F[1, 36]= 0.03, p=0.88). 
 
Significant increase in HR in both groups (F[1, 36]= 68.96, p=0.0001), 
but no significant effect for position (F[1, 36]= 1.89, p=0.18) and no 
position by phase effect (F[1, 36]= 0.002, p=0.96). 
 
The groups did not differ statistically significantly during the HS 
(Mann Whitney U = 158.0; p = 0.56). 
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8 Grunau et al. 
2005  
(Canada) 
Design: Prospective cohort study. 
Settings: Level III NICU.  
Sample: n=87. GA: 22-32 wks, 2 
groups: (1) 22-28, n=30; (2) 29-32, 
n=57.  
PNA: 32 wks + 7 days. 
 
Proportion of ventilated infants was 
not reported  
(mean days=17.52+14.67 days in 
group 1 and 1.40+3.31 days in group 
2. 
No infants with NI were included.  
CFs:  Number 
of prior pain 
exposure, 
severity of 
illness, 
morphine 
exposure. 
Outcome: 
Pain response 
during one 
HS. 
NFCS 
 
 
 
 
 
HR 
 
 
Cortisol levels 
  No significant association between prior pain exposure (skin 
breaking procedures since birth) and facial response to the heel-stick 
in group 2.  After controlling for severity of illness and cumulative 
morphine exposure, the association was not statistically significant 
in group 1. 
 
No statistically significant association between prior pain exposure 
and heart rate variability in either group. 
 
Group 1: controlling for early illness severity and morphine 
exposure, higher neonatal procedural pain predicted lower plasma 
cortisol responses to stress (adjusted R2=0.23; standardized β=-0.59, 
t=-2.22, p=0.039). /  
Group 2: no significant relationships. 
9 Holsti et al. 
2006  
(Canada) 
Design: Randomized-within subjects, 
cross over design. 
Settings: Level III NICU. 
Sample: n=42. GA-25-32 wks (mean 
30 wks) 
PCA: 32 wks + 7 days 
Proportion of ventilated infants was 
not reported (median=5.5+9 days). 
No infants with NI were included.  
CFs: GA, rest 
period (RP) 
versus series 
of routine 
nursing 
interventions 
(clustered 
care -CC) 
prior to heel-
stick, gender.  
Outcome: 
Pain response 
during two 
HS. 
NFCS 
 
 
 
 
 
HR 
 
 
 
Sleep/wake state 
Significant increase in facial activity in both the RP (F=10.1, 
p<0.0001) and CC groups (F=21.6, p<0.0001) with significantly more 
facial activity in the CC group than the RP group during the heel 
lance (t=2.1, p<0.05).  GA was significantly related to facial activity 
(F=4.3, p<0.04) with increased facial response seen only in infants > 
30 weeks of age. No gender effects. 
There was no significant difference in the change in HR from baseline 
to lance in the two care groups and no significant GA or gender 
effects. 
No differences in the sleep/wake state in the RP and CC groups and 
no gender or GA effects.   
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10 Johnston & Stevens. 
1996  
(Canada) 
Design: Cross sectional comparative. 
Settings: Two level III NICU. 
Sample: n=89. 2 groups based on 
PNA at the time of the heel-stick: (1) 
PNA=4 weeks (mean GA=27.3 wks, 
n=36); (2) PNA= 4 days (mean 
GA=32.3wks, n=53). 
PCA: 32 wks + 7 days. 
 
Proportion of ventilated infants was 
not reported.  
No infants with NI were included.  
CFs: PNA, GA, 
5 minute 
Apgar score, 
birth weight, 
weight at 
data 
collection, 
severity of 
illness, 
number of 
painful 
procedures. 
Outcome: 
Pain 
response 
during one 
HS. 
NFCS 
Brow bulge 
 
 
 
 
 
  
Eye squeeze 
 
 
 
 
 
Nasolabial 
 furrow 
 
 
 
 
HR 
 
 
 
 
 
 
 
SaO2 
Group 2 had significantly higher scores (F[1,82]=5.06, p<0.027), there 
was an increase over time (heel-stick phase) (F[3,80]=50.99; p<0.0001) 
and there was a significant group by time effect (F[3,80]=4.80; p<0.004). 
Total number of painful procedures (β=-0.42474; p<0.0003) accounted 
for 18% of the variance. APGAR scores (β=-0.279926, p<0.015) 
accounted for 7.8% of the variance.  Not significant: GA, birth weight, 
weight at data collection, severity of illness. 
Group 2 had higher scores (F[1, 82]=9.85; p<0.001); there was a 
significant increase over time (F[3,80]=36.94; p<0.0001) and there was 
a significant group by time effect (F[3,80]=4.60; p<0.005). Total number 
of painful procedures (β=-0.35131; p<0.001) accounted for 10.9% of the 
variance. Not significant: GA, birth weight, weight at data collection, 
severity of illness, 5 minute APGAR. 
No significant group effects (F[1, 85]=3.23; p=0.076), significant time 
effect (F[3, 83]=134.69; p<0.0001); significant group by interaction 
effect (F[3, 83]=4.40; p<0.039). Total number of painful procedures (β=-
0.40339; p<0.0007) accounted for 16.3% of the variance. APGAR scores 
(β=-0.23259, p<0.05) accounted for 5.4% of the variance. Not significant: 
GA, birth weight at data collection, severity of illness, total number of 
painful procedures. 
HR was significantly higher (F[1, 86]=25.23; p<0.0001) in group 1 & was 
different across HS procedures phases (F[3, 84]=38.77; p<0.0001).  
The interaction between group and phase was not significant (F[3, 
83]=1.96; p=0.126) 
GA at birth (β=-0.34658; p<0.0009) accounted for 12% of the variance. 
Not significant: birth weight, weight at data collection, severity of illness, 
total number of painful procedures, 5-minute APGAR. 
SaO2 was significantly lower for group 1 (F[1, 85]=20.41; p<0.0001) and 
was different across phases of the procedure (F[3, 83]=19.41; p<0.0001) 
but there was no significant group by time interaction (F[3,83]=0.73; 
p=0.538).  
Birth weight (β=-0.34159; p<0.0018) accounted for 11.6% of the 
variance. Not significant: GA, weight at data collection, severity of illness, 
total number of painful procedures, 5 min APGAR. 
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11 Johnston et al.  
1995  
(Canada) 
Design: Crossover. 
Settings: Two level III NICU. 
Sample: n=48.  Mean GA at birth: 
27.5 wks 
PCA: 29wks, ~11 days. 
Ventilated at observation: 49.5%.  
 
No infants with NI were included.  
CF: GA 
Outcome: 
Pain 
response 
during one 
real and 
shame HS. 
NFCS 
Brow buldge 
 
 
HR 
 
HR standard 
deviation 
 
Minimum SaO2 
No significant (1) multivariate GA effect (regardless of condition – real or 
sham and phase). (2) 2-way (age by condition) or (3) 3-way (age by 
condition by phase) effect.  
 
No significant multivariate, 2-way or 3-way effects. 
 
Significant multivariate GA effect (F[5, 35]=3.094; p<0.020) but not 
significant 2-way or 3-way effects. 
 
No significant multivariate, 2-way or 3-way effects. 
12 Johnston et al.  
1996  
(Canada) 
Design: Crossover. 
Settings: Two level II-III NICU. 
Sample: n=28.  Mean GA at birth: 
28.3 wks. 
PNA: 12-59 days. 
 
Proportion of ventilated infants was 
not reported.  
No infants with NI were included.  
CF: PNA, 
ventilatory 
status, 
gender, 
severity of 
illness, 
number of 
painful 
procedures. 
Outcome: 
Pain 
response 
during 
repeated real 
and shame 
HS (4 real 
and 4 shame) 
over 8 weeks. 
NFCS: 
Brow bulge 
 
 
 
 
Eye squeeze 
 
 
 
Nasolabial 
furrow 
 
 
 
 
HR 
 
 
SaO2 
Significant difference across time points (greater responses as PNA 
increased) (F[3, 25]=3.99; p<0.026) and no significant condition (real vs. 
sham HS) by time effect (F[3, 25]=0.999; p=0.409). 
No significant effect for frequency of invasive procedures, severity of illness, 
ventilatory status or gender.  
Significant time (PNA) effect (F[3, 25]=26.225; p<0.0001) and significant 
condition by time effect (F[3, 25]=8.183; p<0.001). 
No significant effect for frequency of invasive procedures, severity of illness, 
ventilatory status or gender.  
Significant time effect (F[3, 25]=6.72; p<0.002) and a significant condition 
by time effect (F[3, 25]=3.38; p<.036). 
No significant effect for frequency 0f invasive procedures, severity of illness 
or gender. Ventilatory status was significantly related to nasolabial furrow 
at time 2 only (t=13.25, p=0.05). 
No significant time effect (F[3, 25]=1.428; p=0.258) or condition by time 
effect (F[3, 25]=0.4162; p=0.743). No significant effect for frequency of 
invasive procedures, severity of illness, ventilatory status or gender.  
No significant time effect (F[3, 25]=0.77; p=0.516) or condition by time 
effect (F[3, 25]= 1.413; p=0.262). No significant effect for frequency of 
invasive procedures, severity of illness, ventilatory status or gender.  
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13 Johnston et 
al.  
1999  
(Canada) 
Design: Cross-sectional design 
based on secondary analysis of 
the control session of a 
randomized crossover design 
(Stevens et al., 1999) 
Settings: Four level III NICU. 
Sample: n=120.  Mean GA at 
birth: 28 wks (27-31) 
PNA: 10 days 
 
Proportion of ventilated 
infants was not reported.  
No infants with NI were 
included.  
CFs: GA, PNA, gender, 
race, medications 
(caffeine or other 
stimulant drugs), 
number of invasive 
procedures, Apgar (5 
minute), time since 
last painful proce-
dure, wake\ sleep 
state. 
Outcome: Pain 
response during one 
HS. 
PIPP The following variables were retained in the final regression model: 
PNA at the time of the study (OR= 0.9975, 95% CI= 0.9944-1.0005); GA at 
time of birth (OR= 0.9351, 95% CI= 0.8883-0.9844); time since last painful 
procedure more recent (OR= 0.9988, 95% CI= 0.9974-1.0002); and 
sleep/wake state (OR= 0.1787, 95% CI= 0.218-1.4664). Younger infants who 
had a lower GA at the time of birth, had a more recent painful procedure 
or\and sleeping were less likely to demonstrate behavioral and physiologic 
indicators. 
14 Morison et al.  
2003  
(Canada) 
Design: Cross-sectional. 
Settings: One level III NICU. 
Sample: n=10.  Mean GA at 
birth: 30.84 wks (23-32). 
PNA: M=30.8, SD=1.58.   
Ventilated at observation: 1 
infant. 
 
Infants with major congenital 
anomalies were not included.  
CFs: GA, Apgar (1 
minute), birth weight, 
number of painful 
procedure from birth 
and in the past 24 
hours, severity of 
illness at day 1. 
Outcome: Pain 
response during one 
HS. 
20s NFCS 
 
 
 
 
Eye squeeze 
 
 
 
 
 
HR 
 
 
 
 
HR variability 
 
 
 
 
 
 
 
 
Total facial responses during the lance were positively related to GA (r=0.49, 
ns), birth weight (r=0.61, p<0.10), APGAR at 1 minute (r=0.80, p<0.001), 
number of invasive procedures during the previous 24 hours (r=0.08, ns) 
and severity of illness (r=0.21, ns) were negatively related to the number of 
invasive procedures since birth (r=-0.60, p<.10). 
Eye squeeze during the lance were positively related to GA (r=0.53, ns), birth 
weight (r=0.49, ns), APGAR at 1 minute (r=0.44, ns). Number of invasive 
procedures during the previous 24 hours (r=0.03, ns) and severity of illness 
(r=-0.43, ns) were negatively related to the number of invasive procedures 
since birth (r=-0.56, p<0.10). 
No significant relationship between post lance HR and GA (r=0.16, ns), birth 
weight (r=0.09, ns), APGAR at 1 minute (r=0.33, ns), number of invasive 
procedures during the previous 24 hours (r=0.40, ns) and since birth (r=-
0.08, ns). Greater Severity of illness in day 1was negatively associated with a 
smaller increase in mean HR (r=-0.77, p<0.05) 
HR variability was negatively correlated with GA (r=-0.64, p<.10), birth 
weight (r=-0.37, ns), APGAR at 1 minute (r=-0.23, ns) and severity of illness 
(r=-0.23, ns) and positively correlated with the total number of painful 
procedures (r=0.37, ns) and the number in the prior 24 hours (r=0.23, ns) 
 
 
 
 
 
  
NIDCAP (stress 
and stability cues 
during the 10 min 
post lance 
compared to 10 
min at baseline) 
Post-heel lance, stress cues were negatively correlated with GA (r=-0.75, 
p<0.05), birth weight (r=-0.73, p<0.05) and APGAR at 1 minute (r=-0.75, 
p<0.05). There were positively correlated with the number of painful 
procedures since birth (r=0.79, p<0.01) and recent painful procedures 
(r=0.32, ns). Stability cues were negatively correlated with severity of illness 
(r=-0.51, ns) and the number of painful procedures since birth (r=0.27, ns) 
although neither correlation was significant (i.e., associated with a p-
value<0.10). 
15 Oberlander 
et al. 2002  
(Canada) 
Design: Cross sectional 
comparative.  
Settings: One level III NICU. 
Sample: n=12 with 
parenchymal brain injury, and 
12 healthy controls with 
similar characteristics. Mean 
GA at birth: 26.3wks (24-28). 
PCA:  32 wks +6 days. 
 
Proportion of ventilated 
infants was not reported. 
CF: Parenchimal brain 
injury. 
Outcome: pain 
response during one 
HS. 
NFCS- total score 
facial activity 
 
NFCS- 
Tongue 
protrusion 
 
NFCS-finger 
splay 
 
HR 
 
Sleep/wake state 
Repeated measures ANOVA showed a statistically significant main effect 
across events (F=16.6;  df 1,50; p <0.01), no significant group differences or 
interaction were found (p<0.05). 
Infants with PBI had significantly higher tongue protrusion at lance (x2 df 
[1]=4.8; p=0.03).  
 
Proportion of infants displaying finger splay increased in both groups 
during heel squeezing but not significantly (x2 df [1]=2.40; p=0.17), with no 
difference between the 2 groups. 
Mean HR increased significantly from baseline to lance (F[1,2]= 57.0; 
p<0.01). No significant group (PBI vs. controls) differences in mean HR.  
No significant differences in the pattern in the two groups. 
16 Porter et al. 
1998  
(USA) 
Design: RCT 
Settings:  One level III NICU. 
Sample: n=48. Mean GA at 
birth: (1) Handled (n=21) 
M=35.3w, (2) Non-handled 
(n=27) M=35.6. 
PNA:  Handled: M=3.2 + 1.4, 
Non-handled: M= 3.3 + 1.2.  
Proportion of ventilated 
infants was not reported. 
CF: Handling. 
Outcome: Pain 
response during one 
HS, one group with 
previous handling 
(n=21), a second- 
without (n=27). 
NFCS  
 
Behavioral state 
 
 
HR 
During the HS phase the handled group showed an average increases in 
facial activity (2.5% vs. 1.5%, p=0.001). 
In response to the HS, handled infants exhibited significantly greater 
increases in behavioral responses (2.91 vs. 1.82, p=0.0001). 
Compared to baseline, during the HS the handled group had a mean HR 
increase of 30.5 + 14.9 bpm and the non-handled group had a mean increase 
of 22.6 + 15.8 bpm (p= 0.03). 
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17 Slater et al. 
2009  
(UK) 
Design:  Observational 
correlational design. 
Settings: Two NICUs. 
Sample: n=95. 25-44 wks 
GA (mean=31.8 wks). 
 
Proportion of ventilated 
infants was not reported 
CFs: PCA, Intra 
ventricular 
hemorrhage (IVH), 
sleep (behavioral) 
state, administration 
of morphine at the 
time of the HS. 
Outcome: The latency 
to the change in facial 
expression during 1-8 
HSs. 
PIPP 
  Any facial  
  Response 
  Time to facial 
   response 
Mean PCA of infants with response was significantly higher than the mean PCA 
of infants with no response (t170=2.50, p=0.013; unpaired 
t-test). Responders were on average 1.6 wks older.  
On multivariate analysis, PCA (standardized β=0.29, p<0.001) and morphine 
administration (standardized β=0.30, p<0.001) were significantly related to 
time to facial expression change while presence of IVH (standardized β=0.12, 
p=0.19) and sleep state (standardized β=0.02, p=0.80) were not significantly 
related. 
18 Stevens et al. 
1994  
(Canada) 
Design: Cross-sectional 
(Secondary analysis for 
Stevens & Johnston, 
1994) 
Settings:  One level III 
NICU. 
Sample: n=124. Mean GA 
at birth: 32.9w (230.6 
days, SD=6.32). 
PNA:  M=3.3 days, 
SD=1.5.   
 
No infants included in the 
study were ventilated. 
Proportion of ventilated 
infants was not reported 
No infants with NI were 
included.  
CFs: Severity of illness 
(Physiologic Stability 
Index-PSI), behavioral 
state, gender. 
Outcome: Pain 
response during one 
HS. 
NFCS 
 
 
 
 
Cry 
When the effect of weight and GA was controlled there was no multivariate 
main of PSI group (F[21, 366]=1.0843, p<0.363) or gender 
(F[7,114]=1.0322, p=0.395) on facial responses; there was a significant for 
behavioral state (F[21,336]=3.20, p<0.0001).   
 
Controlling for weight and GA at the time of data collection, there was a 
significant multivariate main effect of PSI on cry variables (F[12, 153]=2.00, 
p<0.027); no significant effect for behavioral state (F[12,153]=0.56, p<.873) 
or gender (F[5, 109]=1.17, p=0.660)  
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19 Stevens et al. 
1999  
(Canada) 
Design: Prospective 
randomized crossover trail. 
Settings:  Three tertiary 
care NICUs. 
Sample: n=122. Mean GA at 
birth: 28.6+15 wks. 
PNA:  <28 days.  
 
Proportion of ventilated 
infants was not reported. 
No infants with NI were 
included.  
CFs: GA, PNA, severity 
of illness, number of 
painful procedures, 
frequency and 
intensity of 
therapeutic 
procedures (measured 
by the Neonatal Thera-
peutic Intervention 
Scoring System). 
Outcome: Pain 
response during one 
HS in infants 
randomized to one of 
4 groups: (1) control, 
(2) prone position, (3) 
pacifier with water or 
(4) pacifier with 24% 
sucrose. 
PIPP scores GA: Main effect (F[1,122]=20.95, p<0.0001); no significant interaction 
(multivariate)effect  (F[3, 351]=0.42, p=0.738). 
PNA: Main effect (F[1, 118]=19.70, p<.0001); no significant interaction 
effect (F[3, 347]=1.58, p=0.195). 
Severity of illness: Main effect (F[1, 267]=0.85, p=0.36); no significant 
interaction effect (F[3, 355]= 1.97, p=0.118). 
Frequency and intensity of therapeutic procedures: Main effect (F[1, 
267]=5.37, p=0.021); no significant multivariate effect (F[3, 371]=1.44, 
p=0.231). 
Number of painful procedures: Main effect (F[1, 133]=15.78, p<0.0001); 
significant interaction effect (F[3.350]=3.59, p=0.014). 
PIPP scores increased with higher numbers of painful procedures. 
20 Walden et al. 
2001  
(USA) 
Design: Quasi-experimental 
repeated measures design. 
Settings:  Two tertiary care 
NICUs. 
Sample: n=11. GA at birth: 
24-26wks (M=24.63+0.67 
weeks). 
PCA:  27-32 wks  
Ventilated at observation: 
91% (n=10). 
 
No infants with NI were 
included. 
CF: PCA. 
Outcome: Pain 
response during 6 HSs 
per infant at PCA 
(wks): 27, 28, 29, 30, 
31, and 32. 
HR & SaO2 
 
 
 
NIDCAP 
(behavioral 
response to HS) 
 
 
 
 
PIPP 
 
There were no significant differences in heart rate responses between 
27 and 32 weeks PCA (p=0.29). 
 
 
The only variable that showed significant PCA effects was finger splay.  
At 27 weeks, 45.5% of infants showed finger splay during the heel-
stick/squeeze phase compared to 100% of the infants at 32 weeks 
(p=0.03). 
 
 
 
No significant differences in infant response patterns as a result of PCA 
were noted for, brow bulge, eye squeeze, or PIPP scores (p= 0.29). 
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21 Warner et al.  
2001  
(USA) 
Design: Descriptive 
correlational design 
(Secondary analysis). 
Settings:  One level III NICU. 
Sample: n=20. GA at birth: 
30-36wks (mean-32.8wks).  
PNA:  <3 days. 
Ventilated at observation: 
63%. 
 
No infants with NI were 
included. 
CF: Temperament 
(measured by the 
NIDCAP for 2 minutes 
prior to and following 
the HS).  
Outcome: Pain 
response during two 
HS procedures. The 
first between days 1 
and 4 (mean GA =33 
wks 1 day) and the 
second between days 
2 and 15 (Mean GA=33 
weeks 4 days) 
measured by the PIPP 
and NFCS. 
Total motor 
activity 
 
 
PIPP 
 
 
 
 
 
 
Physiological 
responses 
No relationship between mothers’ perception of in-utero or post-birth 
activity levels and total motor activity at the time of HS 1 (r=-0.245) or 2 
(r=-0.002). 
 
There was a significant temperament effect on PIPP scores at HS-1 and 
HS-2.  Mean PIPP scores for low reactivity responders = 8.90+4.90 and 
7.20+9.82 at HS 1 and 2 respectively compared to mean scores of 
9.80+4.47 (HS-1) and 11.70+2.36 (HS-2) for high reactivity responders 
(P<.05 for both HSs).  There were no significant within group 
differences between HS-1 and HS-2 for either group. 
 
Temperament type was not significantly related to physiologic 
responses (HR and SaO2).  
 
22 Williams et al. 
2009  
(USA) 
Design: Longitudinal. 
Settings:  Two tertiary care 
NICUs. 
Sample: n=35. GA at birth: 
<30wks.  
PCA:  26.3 wks + 1.8 days. 
Ventilated at observation: 
63%. 
 
29% of the included infants 
had grade III IVH. 
CFs: PNA , GA, 
ventilation, IVH, recent 
painful procedure 
(within previous 24 
hours), APGAR score 
at 1 or 5 min, race, 
gender, sepsis, severe 
IVH, birth weight, 
length of NICU stay.  
Outcome: Pain 
response during 
multiple HS 
procedures. 
NIPS For each passing week the recorded pain scores increased 0.23 (95% 
C.I= 0.08, 0.37p=0.002). 
No effect on the pain scores by demographic data, IVH, recent painful 
procedure and APGAR score at 1 or 5 min.    
Although GA, birth weight, mechanical ventilation, and length of stay in 
the NICU were significantly related to pain scores when examined in 
individual separate mixed models that included PNA and HS phase, 
when they were included in the same mixed model, only PNA and HS 
phase were significantly associated with pain scores. 
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23 Xia et al.  
2002  
(China‏) 
Design: Cohort longitudinal 
study. 
Settings:  Two tertiary care 
NICUs. 
Sample: n=100. Stratified 
into 3 groups of: (1) 29-
32wks (n=30); (2) 33-
36wks (n=30);  (3) full 
terms (n=40).  
PNA:  5-10 days. 
No ventilated infants were 
included. 
 
No infants with NI were 
included. 
CF: GA.   
Outcome: Pain 
response during one 
HS.  
NFCS 
 
 
 
 
 
 
 
 
 
HR 
The NFCS scores of groups 2 were significantly higher than group 1 
during the HS (M=4.8 + 0.7 vs. 3.7 +2.4, p< 0.05) and squeeze 
(M=5.7+0.6 vs. 4.7+2.5, p< 0.05). 
The mean scores of group 3 were also significantly higher than those of 
group 1 during HS (5.1+1.8 vs. 3.7+ 2.4, p< 0.01) and squeeze (6.2+0.9 
vs. 4.7+2.5, p< 0.001).  
Significantly more infants in group 3 showed horizontal (n=21, 53% vs. 
6, 20%, p<0.01) taut tongue (n=34, 85% vs. 19, 63%, p<0.05) and hand 
to mouth (n=14, 35% vs. 3, 10%, p<0.05) behaviors than group I. 
 
While mean heart rate increased significantly compare to baseline in all 
three GA groups, there were no significant differences in the mean heart 
rates during the heel lance (group 1=152.5+17.9, group 2=155.6+15.2, 
group 3=154.7+17.2). There were significant GA group differences in 
maximal heart rate variability (group 1=16.8+12.2, group 2=16.2+11.3, 
group 3=23.3+12.2; p<0.05) in HR variability. 
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ABSTRACT  
Background: Evidence indicates that medical and demographic contextual factors (CFs) 
impact pain responses in preterm neonates, but the existing evidence is very heterogeneous. 
Aim: To explore the effect of CFs on pain responses to heel-stick procedures of preterms  
infants. 
Methods: This study was a secondary analysis of data collected during a randomized 
controlled trial examining pain response to non-pharmacological interventions across repeated 
heel-sticks. Five heel-sticks across the first 14 days of life were videotaped. Pain response was 
rated with the Bernese Pain Scale for Neonates (BPSN) by four raters blinded to the heel-stick 
phases (baseline, heel-stick, and recovery). Demographic and medical CFs were extracted from 
medical charts. Mixed single and multiple regression analyses were performed controlling for 
the intervention group, site and heel-stick phase.  
Results: Apgar scores at 1 minute were negatively associated with behavioral (p=0.002) 
BPSN scores, while Apgar scores at 5 minutes after birth were positively associated with 
behavioral (p=0.006) scores. Accumulated number of painful procedures (p=0.002) and gender 
(p = 0.02) were positively associated with physiological scores while CPAP (p=0.009) and 
mechanical ventilation (p=0.005) were negatively associated.   
Conclusion: Higher exposure to painful procedures, male infants and having CPAP or 
mechanical ventilation were CFs associated with physiological response. The only variables 
significantly associated with behavioral BPSN scores were Apgar scores but these relationships 
were inconsistent.  
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6.1 BACKGROUND 
Pain management in neonates remains an important area for research and discussion, 
despite significant progress over the past 25 years. In particular, comprehensive pain assessment 
that considers preterm infants’ differing neurologic and developmental status is urgently needed 1. 
Physiologic and behavioral pain responses in preterm infants show high variability 2, are less 
vigorous than in term infants, and influenced by more than the invasive procedure itself 3. Medical 
and demographic contextual factors (CFs) (e.g. gestational age, previous pain exposure, and 
severity of illness) appear to impact pain response and failure to understand their impact can lead 
to erroneous pain assessment 4-9. A recent systematic review revealed associations between CFs 
(e.g., GA, postnatal age, previous pain exposure) and pain response 10, but findings were 
inconsistent. Thus, the impact of CFs needs to be further explored to determine which CFs need to 
be taken into consideration when evaluating the preterm infant’s pain response, particularly 
behavioral components of their response 2,11-13. Furthermore, based on the repeated 
recommendations to assess pain multidimensionally, it is imperative that the impact of CFs on 
both behavioral and physiological pain responses should be examined. 
Multidimensional pain assessment is important due to the complexity of pain in preterm 
infants. Johnston and Stevens 7 reported that preterms demonstrated physiological changes, 
including decreases in oxygen saturation (SaO2) and increases in heart rate (HR), in response to 
painful events across time, but behavioral responsiveness was blunted. Contextual factors may 
explain both the variability in pain response between and within preterm infants and the low 
correlation between behavioral and physiologic responses 2,7,14. While there is evidence that 
non-pharmacological interventions are effective in reducing acute pain in minor and moderate 
procedures in preterms 15,16, their impact is variable, and may be influenced by CFs. Slater and 
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colleagues 17 compared behavioral pain responses [measured using Premature Infant Pain 
Profile (PIPP) scores] and pain–specific brain and spinal cord activity to a noxious stimulus in 
newborns receiving sucrose compared to sterile water. PIPP scores were significantly lower in 
infants receiving sucrose, but there were no significant differences in the latency of the 
nociceptive brain activity between the two groups. Although the findings of this study were 
heavily criticized in terms of methodology 18-22, these findings were not examined in relation to 
CFs, which might have had an influence on the results reported.  
In this sub study we explored the association between medical and demographic CFs and 
behavioural and physiologic pain responses to heel-stick procedures in preterm infants (<32 
weeks of gestation). 
6.2 METHODS 
6.2.1 Design, Sample and Setting  
This secondary data analysis utilized data collected during a multicenter randomized 
controlled trial using a repeated measures design to examine pain responses of three groups of 
preterm infants receiving non-pharmacological pain relief interventions across repeated routine 
heel-sticks 14. Seventy-one premature infants between 24 and 32 weeks of gestation needing 
neonatal intensive care were recruited during the first 2 days of life in three University Hospital 
neonatal intensive care units (NICUs) in Switzerland (Basel, Zurich and Bern). Infants were 
randomly assigned to one of three intervention groups receiving (1) oral sucrose, (2) facilitated 
tucking, or (3) combined oral sucrose and facilitated tucking. Infants were stratified by GA prior 
to randomization: (1) 24-28 weeks, and (2) 29-32 weeks. Five heel-sticks during the first 12-14 
days of life were videotaped for each infant and pain was scored by four independent raters, 
who were blinded to the phase (baseline, heel-stick, and recovery) of data collection. The 
videotaping procedure was designed to ensure that the raters could not see if the heel-stick 
procedure was being performed. 
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Infants admitted to the NICU during this time period were assessed for eligibility 
according to predefined inclusion and exclusion criteria. Inclusion criteria were: preterm infants 
born between 24 0/7 and 32 0/7 weeks of gestation, anticipation of at least five routine heel 
capillary blood samples over the first 14 days of life and parental consent. Infants were excluded 
if they had a high grade intra-ventricular hemorrhage (III and IV grade), severe life-threatening 
malformations or a congenital malformation affecting brain circulation or the cardiovascular 
system, had undergone a surgical procedure, had blood pH of less than 7.00, had any condition 
involving partial or total loss of sensitivity or had any reason that could cause inability to 
express pain. Infants treated with mechanical ventilator or CPAP (continuous positive airway 
pressure) were included if they met other eligibility criteria (for detailed information regarding 
the study procedure, please see Cignacco et al., 2012).  
6.2.2 Variables and Measures  
 6.2.2.1 Pain predictor variables (CFs) 
The CFs were chosen based on the findings of our recently published systematic review 10. 
The following CFs were significantly associated with pain response in several studies. 
Demographic CFs included: birth weight; gender; post-natal age (PNA) measured as weeks 
and days since birth documented for each heel-stick being videotaped; gestational age (GA) 
measured as weeks and days at birth and post-menstrual age (PMA). PMA was calculated by 
combining GA at birth with PNA (GA at birth + PNA = PMA) 23. All demographic data except post-
natal and post-menstrual ages were documented at the beginning of data collection. Medical CFs 
included: Apgar scores at 1 and 5 minute after birth; medications - daily doses of: sedatives 
(Propofol lipoid, Phenobarbital, Valium, Midazolam, and Chloralhydrate); narcotics (Morphine, 
Fentanyl, Pethidin, and Remifentanyl) and non-narcotics (Paracetamol, Tylenol, and Becetamol) 
pain relief medications, steroids and caffeine given during the 14 days of data collection; the 
number of previous procedures - painful and uncomfortable diagnostic and therapeutic 
procedures; the duration of the heel-stick procedure; CPAP or mechanical ventilation at 
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the time of the heel-stick procedures; the seven most common co-morbidities seen in preterm 
infants during a NICU stay (broncho-pulmonary dysplasia, necrotizing entero-colitis, respiratory 
distress syndrome, patent ductus arteriosus, septic events, cardiac events, and respiratory 
arrest). 
 6.2.2.2 Measurement of Pain Response 
Pain response was the dependent variable in this study and was measured by the BPSN, a 
nine-item instrument, which includes three physiologic (HR, respiratory rate, and SaO2) and six 
behavioral (grimacing, body movements, crying, skin color, sleeping patterns, consolation) items. 
As the infants were continuously monitored, HR and SaO2 were downloaded from the clinical 
database for the same time frame as the three phases of the data collection. Respiratory rate was 
counted by the raters during the rating of the video sequences. Each item was scored on a 3-
point scale (range 0-3); for the behavioral items higher scores indicated greater distress while 
for physiological items it was a greater change from baseline. The BPSN is a valid and reliable 
pain assessment instrument for preterm and term infants currently widely used in Swiss and 
some German NICUs. Cignacco et al. 24 performed a validation study of the BPSN. Construct 
validity was good (f = 41.3, p < 0.0001) and concurrent and convergent validity of the BPSN 
compared to VAS (Visual Analogue Scale) and PIPP were r = 0.86, and r = 0.91, p < 0.0001, 
respectively. Initial psychometric testing (Brunner et al., 2011, unpublished) of the BPSN 
instrument supported good construct validity with differentiation between painful and non-
painful procedures (f = 41.27, p < 0.0001), inter-rater reliability coefficients of r = 0.86 – 0.97 
and intra-rater reliability coefficients of r = 0.98 to 0.99. For the purpose of this study, inter-
rater reliability testing was performed and the Cronbach’s alpha ranged from 0.90 and 0.95 for 
the different phases. Based on this high inter-rater reliability, mean BPSN scores were calculated 
across the raters and used in the analysis. For this instrument, a score of 11 or less is considered 
non-painful. Based on previous studies reporting low correlations between the behavioral and 
physiological dimension of pain assessment 2,7,14, two BPSN scores were calculated: a behavioral 
BPSN score (B-BPSN); and a physiological BPSN score (P-BPSN). 
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 6.2.3 Ethical Considerations  
The randomized controlled trail (RCT) was approved by the ethical boards of the Canton 
Basel, Bern and Zurich. Potential infant participants were screened by a trained study nurse.  
Written informed consent was obtained from a parent according to the protocol approved by the 
ethical boards. The RCT was registered, number NCT00758511 in http://www.clinicaltrials.gov. 
 6.2.4 Data Collection 
Data for the CFs were collected using an investigator-developed data collection sheet. Data 
on pain responses were collected during five routine heel-sticks (T1-T5) performed between 
postnatal day 2 and 16 as part of the neonate’s routine clinical care. The first data collection (T1) 
was performed no later than the fourth day of life. All heel-sticks procedures were videotaped in 
three phases (baseline, heel-stick, and recovery). In total, 1065 sequences were produced; ten 
sequences were discarded due to quality problems (in terms of ability to rate the sequence). 
DVDs were prepared for the rater with the 1055 sequences presented in random order in 
relation to the number of the heel-sticks being recorded (T1 – T5) and the phase (baseline, heel-
stick, recovery phase) of the procedure. The DVDs were provided to four trained nurses for 
assessment of pain responses during each sequence. Raters scored the behavioral items and 
breathing; HR and SaO2 data were added and the total pain scores were calculated by the first 
author (GS) and a research assistant. The raters rated the video sequences independently at 
their own pace within a time period of two months. Relationships between these data and the 
interventions are reported elsewhere 14. 
 6.2.5 Data Management and Analysis 
Descriptive statistics (means, standard deviations (SD), frequencies, and/or inter quartile 
ranges depending on level of measurement and distributional properties) were used to describe 
the demographic and medical characteristics of the infants. Mean number of painful procedures 
was compared per GA group utilizing a t-test. The correlation between physiological and 
behavioral items of the BPSN was calculated with Pearson correlation coefficient. We 
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logarithmically transformed the BPSN scores to obtain normally distributed residuals. The CFs 
were tested for possible association with mean BPSN scores (behavioral, and physiologic) across 
all 5 heel-stick procedures during the heel-stick and recovery phases using random intercept 
regression analysis, with infants as the random variable and CFs as fixed effects. The analysis 
controlled for the baseline phase BPSN score of each heel-stick, non-pharmacological 
intervention group, and site. We screened each CF separately in a simple mixed regression 
model and included only those which reached a probability level of p < 0.20 in the multiple 
regression models. During the analysis we observed co-linearity between GA and PNA.  
Consequently, we used only the post-menstrual age in the multivariate analysis. Apgar scores at 
5 minutes, PMA and accumulated number of painful procedures were included in the 
multivariate models as well (even if not reaching a probability level of p < 0.20), as we 
hypothesized they might be associated with pain response based on findings from previous 
studies 10. The final alpha of the mixed regression models was considered to be significant if p < 
0.05. Data were analyzed using IBM SPSS statistics software® version 19 (IBM, Inc., Armonk, NY, 
USA) and SAS version 9.1 (SAS Institute, Inc., Cary, NC, USA). 
6.3 RESULTS 
6.3.1 Sample characteristics  
Between January 2009 and December 2010, a total of 201 infants were assessed for eligibility; 
130 infants were excluded due to various reasons (e.g. not meeting inclusion criteria, parents 
declined participation, enrolled in another study etc.) 14 and 71 infants were enrolled in the study. All 
but one completed the data collection period of five heel-sticks. The fifth heel-stick was missed for 
one infant. The mean GA of the total sample at birth was 29.24 (+1.83) weeks, with a mean PMA at 
heel-stick 1 of 29.58 weeks (+1.81), and 30.64 (+1.82) at heel-stick 5. The mean birth weight was 
1174.44 grams (+337.00). Mean number of co-morbidities per infant was 1.59 (+1.39). While 25.4% 
(n = 18) of the infants had no co-morbidities, 2.8% (n = 2) had a total of five co-morbidities. None of 
the infants had necrotizing enterocolitis. The mean (M) number of painful procedures during the 
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first 14 days of life was 201 (+104.1) procedures per infant [14.38 (+ 7.43) per day]. There were 
significant differences in the mean number of painful procedures between the two GA groups (p < 
0.0001) with the younger group having twice as many procedures (M = 21 +9.0/day) than the older 
group (M = 11 +7.0/day). There were also significant differences in the number of painful 
procedures between recruitment site I (M = 18.5 +10.2/ day, p < 0.001) and site II (M = 7.8 +4.0/day) 
and between site II and site III (M = 16.9 +6.2/day, p < 0.001) but not between site III and site I. 
There were no significant differences in the demographic characteristics of the non-pharmacological 
interventions groups. The sample characteristics are summarized in table 1. 
Table 1: Demographic characteristics of the sample  
Demographic characteristic   n (%) 
Sample   71 (100) 
Gender Female 32 (45.00) 
  Male 39 (55.00) 
Ventilation  HS 1 4 (5.60) 
  HS 2 3 (4.20) 
  HS 3 2 (2.80) 
  HS 4 0 (0) 
  HS 5 0 (0) 
CPAP  HS 1 28 (39.40) 
  HS 2 22 (31.00) 
  HS 3 22 (31.00) 
  HS 4 18 (25.40) 
  HS 5 17 (23.90) 
Co-morbidities Broncho-pulmonary disease 6 (8.50) 
  Respiratory distress syndrome 44 (62.00) 
  Patent ductus arteriosus 14 (19.70) 
  Septic events 8 (11.30) 
  Cardiac events 22 (31.00) 
  Respiratory arrest 19 (26.80) 
GA at birth (weeks)   29.24 (1.83) 
PMA at time of HS (weeks) HS 1 29.58 (1.81) 
 HS 5 30.64 (1.82) 
Birth weight (gr)  1174.44 (337) 
Apgar scores 1 min 5.97 (2.19) 
 5 min 7.58 (1.61) 
Number of painful procedures per day   14.38 (7.43) 
Number of HS per infants per day  1.07 (1.21) 
Duration of HS (minutes)  4.86 (4.35) 
GA= gestational age; HS=heel-stick;  PNA= post-natal age 
CONTEXTUAL FACTORS - SUB-STUDY 
130 
6.3.2 Pain response 
The correlations between the behavioral and physiological pain scores were low for all five 
heel-sticks (r = 0.179 - 0.396). 
6.3.3 Contextual factors associated with BPSN scores  
Although data about medication administration was collected, very few of the infants 
received any of the target medications. Consequently, medication was not included in the 
regression model (behavioral or physiological). Table 2 presents the simple regression models 
results. The multivariate models of the B-BPSN and P-BPSN scores are presented in table 3. 
Based on the univariate results, when examining the mixed model with B-BPSN scores as 
the outcome, we included cardiac events (p = 0.189), Apgar scores at 1 minute (p = 0.080), and 
weight (p = 0.135) as well as Apgar scores at 5 minutes (p = 0.424), PMA (p = 0.395) and 
accumulated number of painful procedures (p = 0.331). Most of the examined CFs were not 
significantly associated with the behavioral scores, 1 minute Apgar was negatively associated (p 
= 0.002) and 5 minute Apgar was positively associated (p = 0.006) with the B-BPSN scores. 
For the mixed regression model with P-BPSN scores as the outcome, we included gender (p = 
0.012), CPAP (p = 0.162), mechanical ventilation (p = 0.009), respiratory distress syndrome (p = 
0.113), PMA (p = 0.009), weight (p = 0.103), duration of heel-stick procedure (p = 0.068) and 
accumulated number of painful procedures (p = 0.011). Apgar scores at 1 minute (p = 0.428) and 
Apgar scores at 5 minutes (p = 0.526) were included in the model as well. In the multivariate model 
PMA was no longer significant (p = 0.878). Weight (p = 0.330), Apgar 1 and 5 minutes (p = 0.771 and 
0.551 respectively) remained non-significant. Male infants showed higher P-BPSN scores (p = 0.020). 
Mechanical ventilation (p = 0.005) and CPAP (p = 0.009) at the time of heel-stick were negatively 
associated with P-BPSN. Infants exposed to a higher number of painful procedure showed higher 
physiological scores (p = 0.002). Although not statistically significant, there was trend for P-BPSN 
scores to increase as the duration of the heel-stick increased (p = 0.055). 
  
Table 2: Contextual factors influencing pain response – simple mixed regression model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*p<0.05 ; **p<0.01  SE= standard error df= degrees of freedom HS= heel-stick GA= gestational age PMA= postmenstrual age 
 Behavioral BPSN scores Physiological BPSN scores 
Contextual factor Β SE df t-value p-value β SE df t-value p-value 
GA-groups  -0.194 0.308 63.188 -0.630 0.531 0.123 0.153 65.472 0.801 0.426 
Gender  0.118 0.296 63.111 0.400 0.690 0.367 0.141 65.502 2.597 0.012* 
CPAP  0.180 0.275 304.213 0.655 0.513 -0.215 0.153 219.292 -1.404 0.162 
Mechanical ventilation  -0.046 0.701 461.708 -0.067 0.947 -1.053 0.399 329.658 -2.639 0.009** 
Broncho-pulmonary dysplasia  0.204 0.524 62.752 0.390 0.698 -0.041 0.262 64.463 -0.158 0.875 
Respiratory distress syndrome  0.142 0.334 62.639 0.426 0.671 0.262 0.163 64.252 1.606 0.113 
Patent ductus arteriosus -0.383 0.364 63.724 -1.052 0.297 -0.174 0.182 65.896 -0.954 0.344 
Septic events 0.046 0.457 62.527 0.102 0.919 -0.160 0.228 64.973 -0.704 0.484 
Cardiac events  0.628 0.472 63.029 1.328 0.189 0.106 0.238 64.463 0.448 0.655 
Respiratory arrest  0.291 0.407 63.569 0.717 0.476 0.223 0.202 65.370 1.104 0.274 
PMA -0.187 0.220 692.968 -'0.852 0.395 0.344 0.131 676.836 2.627 0.009** 
Apgar (1 min) -0.121 0.068 62.706 -1.779 0.080 -0.027 0.034 64.541 -0.798 0.428 
Apgar (5 min) 0.077 0.096 63.885 0.806 0.424 -0.030 0.048 67.493 -0.638 0.526 
Weight -0.0006 0.0004 64.364 -1.512 0.135 0.0003 0.0002 65.742 1.655 0.103 
Duration of HS procedure 0.014 0.036 673.645 0.382 0.702 0.040 0.022 686.621 1.825 0.068 
Number of painful procedures -0.001 0.001 468.821 -0.974 0.331 0.002 0.0009 347.094 2.551 0.011* 
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Table 3: Contextual factors influencing pain response – multivariate mixed regression model  
Outcome  
variable 
Contextual factor β SE df t-value p-value 
B-BPSN Cardiac events  0.571 0.456 62.366 1.253 0.215 
 PMA 0.288 0.371 390.406 0.775 0.439 
 Apgar (1 min) -0.289 0.087 60.765 -3.289    0.002** 
 Apgar (5 min) 0.347 0.122 61.293 2.831    0.006** 
 Weight -0.0007 0.0004 68.224 -1.793 0.077 
  
Number of accumulated 
painful procedures 
-0.002 0.001 459.340 -1.346 0.179 
P-BPSN Gender  0.324 0.136 65.102 2.381   0.020* 
 CPAP  -0.400 0.152 252.950 -2.618     0.009** 
 Mechanical ventilation  -1.106 0.393 263.964 -2.809     0.005** 
 
Respiratory distress 
syndrome  
0.286 0.156 61.842 1.833 0.072 
 PMA 0.051 0.221 351.397 0.234 0.815 
 Apgar (1 min) -0.004 0.044 58.539 -0.101 0.920 
 Apgar (5 min) -0.036 0.063 63.025 -0.571 0.570 
 Weight 0.0004 0.0002 71.562 1.959 0.054 
 Duration of HS procedure 0.043 0.022 685.427 1.952 0.051 
  
Number of accumulated 
painful procedures 
0.003 0.0009 458.362 3.088     0.002** 
*p<0.05 ; **p<0.01 
B-BPSN= behavioral BPSN scores P-BPSN= physiological BPSN scores 
PMA= post-menstrual age HS= heel-stick SE= standard error df= degrees of freedom 
6.4 DISCUSSION  
Mechanical ventilation or CPAP at time of heel-stick, gender and accumulated number of 
painful procedures were the CFs associated with changes in physiological pain scores. Only 
Apgar scores at 1 and 5 minutes after birth was associated with behavioral pain scores. 
Generally, the CFs under investigation influenced P-BPSN rather than B-BPSN scores. 
In the present study, there was a low correlation between the behavioral and physiological 
BPSN scores across the 5 heel-sticks (r = 0.179 - 0.396).  This finding is consistent with previous 
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studies 1,2,25,26. In addition, studies showed that behavioral response varied across infants. 
Johnston et al. 27 reported that some of the infants had no cry response during skin-breaking 
procedures. This phenomenon was explained in part, by examining the CFs associated with 
different pain responses 10. One explanation for the low correlation may be that behavioral and 
physiological factors represent different components of the complex response mounted to 
combat painful insult.  
Apgar scores at 1 and 5 minutes were found to be associated with B-BPSN scores but not 
with the P-BPSN. Some studies have examined Apgar scores as CFs influencing pain response. All 
but one examined only one of the Apgar scores. Grunau et al. 5 and Johnston et al. 28 examined 
Apgar scores at 5 minutes and did not find any association with either behavioral and physiologic 
pain responses. The only study examining both Apgar (at 1 and 5 minutes) scores did not find 
them to be significantly associated with behavioral pain responses, measured by the NIPS 
(Neonatal Infant Pain Scale) 29. Johnston and Stevens 7 examined the relationships between pain 
responses and 5 minute Apgar scores, using the Neonatal Facial Coding System (NFCS), HR and 
SaO2. Apgar scores were found to be associated with NFCS but not with the physiologic measures. 
Our findings that higher Apgar scores at 5 minutes were associated with higher B-BPSN scores 
were consistent with Johnston and Stevens’ results. Morison et al. 30 examined the association 
between Apgar scores at 1 minute and NFCS and physiological parameters (HR and HR variability) 
in 10 preterm infants. The Apgar score (1 min) was significantly related to NFCS scores but not to 
physiologic scores. Apgar scores at 1 minute were positively associated with behavioral pain 
scores, i.e. infants with lower Apgar scores at 1minutes had lower behavioral scores. In contrast, 
we found a negative association between Apgar scores at one minute and B-BPSN scores. One 
explanation for this inconsistency may be the limited reliability of Apgar scores in preterm infants 
31. Further research is needed in order to have a better understanding of these clinical parameters 
and how they relate to preterms’ pain responses. 
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We found a significant positive relationship between the number of previous painful 
procedures and physiological pain responses measured by the P-BSPN but no significant 
association with B-BPSN scores. In previous studies, the number of previous painful procedures 
was one of CFs most often associated with pain responses. Most of studies finding this 
association examined pain response with the PIPP which includes HR and SaO2 in calculation of 
the total score, but behavioral and physiologic scores were not examined separately 4,28,32. 
Johnston and Stevens 7 however, examined both physiologic (HR and SaO2) and behavioral 
responses measured by the NFCS. They compared two groups of infants; one born at 28 weeks of 
gestation and assessed at 32 weeks the second born at 32 weeks and assessed within 4 days. The 
number of previous invasive procedures was the variable that explained most of the variance in 
facial pain response.  They did not, however, find the same effect on the physiological scores. 
Exposure to repeated pain can alter pain processing and can cause neurological damage due to 
the immaturity of the preterm nervous system 33,34. Our findings indicate that infants who were 
exposed to a higher number of painful procedures had greater physiologic response.   
Infants treated with mechanical ventilation and CPAP during the heel-stick showed lower 
P-BPSN pain responses. However, no association was found with B-BPSN. Our results are not in 
line with the existing literature. Johnston et al. 35, Grunau et al. 5, and Williams et al. 29 found no 
association between ventilatory status and either behavioral or physiologic pain scores. 
Williams et al. 29 reported that mechanical ventilation was significantly related to behavioral 
pain scores when examined bivariately. However, when examined in a multiple mixed model 
with other CFs that were significantly related to pain responses bivariately, mechanical 
ventilation was no longer significant. While the reason that our findings were not consistent 
with previous research is unclear, none of the previous studies examined the association 
between mechanical ventilation and pain responses in infants being treated with non-
pharmacological interventions during painful procedures    
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In our study, gender was associated with physiologic scores. Boys had a higher physiologic 
pain response than girls. We did not find significant associations between gender and behavioral 
pain response. Our findings were not consistent with two previous studies examining the 
relationship between gender and physiologic responses and pain 35,36, which both found no 
significant relationship. The reason our findings were not consistent with Johnston and Holsti’s 
findings is unclear as in the exploratory analysis of the parent study (RCT), no further significant 
differences in the characteristics of boys and girls were found. Valerie and colleagues 37 examined 
pain reactivity in male and female preterms as measured by the NFCS, sleep-wake state and HR. 
They found no significant behavioral differences between boy and girls but did find significant 
differences in the magnitude of HR response. Boys demonstrated higher HR changes from baseline 
to heel-stick. Due to the inconsistent results in the existing literature, further research is needed to 
determine if there are gender differences in preterm infants' pain responses, and to explore 
reasons for these differences.   
Infant age has been the most commonly examined CF in relation to pain responses 10. To 
take into consideration both GA and age since birth (PNA) we combined GA and PNA in to one 
variable, post-menstrual age (PMA). PMA was not significantly associated with any kind of pain 
response (behavioral or physiologic) in our study.  Mixed findings regarding the association 
between preterm age variables and both behavioral and physiologic pain response were 
described recently 10. These conflicting findings support the need for additional research 
examining these relationships and possible explanations for the variability in findings. One 
possible explanation is the other CFs (in addition to the age variable) that studies examined.  
6.4.1 Limitations and strengths 
There are a number of limitations that need to be considered when interpreting the findings 
of this study. This study is a secondary data analysis and the parent study was not designed to 
specifically examine CFs.  Consequently, some potentially informative CFs such as an overall 
measure of severity of illness was not examined. Furthermore, the number of infants with some 
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CFs was small (e.g. medications, co-morbidities) which may have limited our ability to detect 
significant effects during the bivariate analysis.  While we were able to include a variety of CFs in 
the multivariate analysis, a larger sample would have allowed us to include more CFs in the 
multivariate models. The small sample size could also be one explanation for the limited results of 
the present study. 
This study also has a number of strengths. We examined a variety of CFs that previous 
studies have suggested may influence preterm infants' pain responses. The use of multivariate 
analysis while controlling for potential confounders as site, non-pharmacological intervention 
group and phase 1 allowed us to examine the independent contribution of each examined CF in 
explaining pain responses. A further strength of this study was the utilization of a pain 
assessment instrument that allowed us to examine the impact of the CFs on both behavioral and 
physiologic pain responses.   
6.5 CONCLUSIONS 
The findings of this study reinforce the importance of CFs in pain response and the need 
for their consideration in pain assessment. We also confirmed the low correlation between 
behavioral and physiologic pain scores in preterm infants. These findings support the need for 
pain assessment instruments that incorporate both behavioral and physiologic measures as 
these measures represent different constructs. Our findings also add to the growing body of 
research that suggests that CFs need to be considered when assessing pain in this population. 
However, given that findings about the impact of CFs are mixed and not definitive across studies 
and within the results of the present study, additional research is needed to determine the CFs 
that need to be incorporated into pain assessment instruments. Multi-center studies are 
recommended to ensure that sample sizes are large enough to permit the examination of 
multiple CFs analyzed in multivariate models. Studies should examine the impact of CFs on both 
aspects of pain response (behavioral and physiologic).     
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 SYNTHESIS, DISCUSSION, AND PERSPECTIVES 
This dissertation addressed a gap in the existing literature regarding the comparative 
effectiveness of two non-pharmacological interventions (NPI) over time, and the association of 
contextual factors (CFs) with pain response of preterm infants receiving these interventions. 
The unique physiology of preterm infants continues to provide major challenges to both 
practical and academic arenas.  Due to reproductive technologies and higher maternal age, 
preterm birth rates have been increasing worldwide 1. Moreover, significant advances in medical 
technology have contributed tremendously to the increased survival of critically ill preterms 2. 
Preterm infants, as an extremely vulnerable population due to their rapidly developing central 
nervous system, are exposed to enormous amount of procedural pain which can cause short and 
long term adverse effects 3. Therefore comprehensive pain assessment followed by pain 
treatment is an essential key to safer development and improved outcomes for these infants. An 
impressive increase in the body of evidence about neonatal pain assessment and treatment has 
appeared since the recognition that the fetus actually can feel pain 4-6. Despite the evidence 
existing on pain management methods, the number of uncomfortable and painful procedures 
being performed in the NICU setting on preterms is still enormous, and pain treatment is still not 
optimal and not universally administrated despite existing recommendations of the American 
Academy of Pediatrics and the Canadian Pediatric Society 7-13. Non-pharmacological pain relief 
interventions are recognized as one of the important keys for coping with the challenge of high 
pain exposure in preterms. There is evidence to support their effectiveness for pain treatment 
during minor painful procedures 14,15.  Despite the extensive existing knowledge regarding the 
benefits of NPIs, information about their efficacy and safety over time is limited, along with 
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research about the comparative effectiveness of these interventions. Therefore, there is a need 
for well-designed research studies to address this gap in knowledge.  
While there is compelling evidence that pain is a major problem in preterm neonates and 
that it may have a sustained negative impact on their development, the challenges of assessing pain 
are also widely recognized. Nowadays term and preterm pain is recognized as a complex experience 
involving not only the functional dimension, but also cognitive and emotional processing 16. Accurate 
pain assessment is an essential pre-requisite to safe and efficacious pain treatment. Great advances 
have been made in pain assessment in this population over the past quarter century. However, 
assessing pain in preterms remains one of the most difficult challenges facing clinicians, researchers, 
and parents due to infants’ incapacity for verbal report. Substantial evidence confirms that preterm 
and term infants have the autonomic and functional capacity for mounting a response to noxious 
stimulation 4,17,18. Currently, pain assessment instruments rely on the different dimensions of pain 
responses such behavioral (e.g. facial, body movement, crying) and physiological measures (e.g. 
increase heart rate, decreased oxygen saturation, increased breathing rate) to diagnose pain in 
infants. Another focus of pain assessment taking place in the research arena is the role of medical 
and demographic CFs in pain responses 19. High variability in pain responses of preterm infants 
receiving the same noxious stimulation was found by Cignacco et al. 20, which could not be explained 
by the painful insult alone, suggesting that CFs can explain this high variability. Most of the studies 
examining CFs influencing pain response have found age variables [e.g. gestational age (GA), post-
natal age (PNA), and post-conceptual age] to be the most influencing factors 21-30; however, other 
studies have not supported these relationships 31-36. Other important CFs identified in studies is 
number of previous exposures to pain 24,25,34 and severity of illness 7,21, but similar to the age 
variables, the results are inconsistent. These inconsistencies demand a deeper exploration in to this 
complex phenomenon of CFs, their influence on pain response with NPIs and their place in pain 
assessment. 
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The findings of the studies of this thesis added to the knowledge base on preterm neonatal 
pain by (1) comparing the effectiveness of two NPIs, sucrose and facilitated tucking (FT), over 
repeated minor painful procedures; (2) systematically examining published evidence on the 
impact of CFs on neonatal pain responses; and (3) providing an insight in to the association 
between numerous CFs and pain response of preterm infants under the therapeutic effect of 
sucrose and FT. These three contributions provide a basis for further discussion around the 
challenges in assessing and managing pain in preterms. 
The parent study (chapter 3) was an RCT, which compared the effectiveness of sucrose, 
FT, and the combination of the two interventions across five heel-sticks in preterm infants. 
While sucrose was significantly more effective than FT, the combination of the two procedures 
was significantly more effective than sucrose only in the recovery phase. In this context of the 
effectiveness of sucrose and FT, our research team and others have found variability in pain 
response, which prompted us to examine the influence of CFs on preterm infants’ pain 
responses. During the data collection phase of the parent project, a systematic review was 
carried out in order to examine the existing literature about CFs influencing pain responses. 
While the results of this systematic review did not reveal any CF that was consistently related to 
pain responses in preterm neonates, the three factors that were most consistently related were 
GA, previous pain exposure, and severity of illness (chapter 5). Subsequently, an exploratory 
sub-study of the parent study examined eleven CFs for their association with pain response 
under the therapeutic effect of sucrose and FT. The results of this study showed an association of 
Apgar scores at 1 minutes and 5 minutes after birth for the behavioral BPSN scores, while the 
accumulated number of painful procedures, having CPAP or mechanical ventilation, and gender 
were associated with the physiological BPSN scores. Our finding reinforce the importance of CFs 
in pain response and the need for their consideration in pain assessment. We also confirmed the 
low correlation between behavioral and physiologic pain scores in preterm infants. Our findings 
also add to the growing body of research that suggests that CFs need to be considered when 
assessing pain in this population. However, given that findings about the impact of CFs are 
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mixed across studies, additional research is needed to determine the CFs that need to be 
incorporated into pain assessment instruments. Furthermore, this study contributes some 
insights in to the complexity of analyzing the association between pain responses and CFs, and 
their integration into the pain assessment process (chapter 6).   
In the following pages we discuss the limitations and findings of this dissertation taking a 
broad perspective that goes beyond the discussion of the individual manuscripts (Chapters 3 to 6). 
Implications for further research and suggestions for clinical practice will also be presented. 
7.1 METHODOLOGICAL ISSUES RELATED TO PAIN ASSESSMENT  
7.1.1 Pain assessment measures, how should clinicians choose?  
The gate control theory 37 shaped the conceptualization of pain mechanism in the early 
1960s. This theory changed and shaped the way we think about pain today. Subsequently, the 
principles of this basic theory were substantiated which reinforced its conceptual value and 
utility over time 38,39. The most important contribution of this theory according to Melzack 40 is 
that pain is a multidimensional experience produced by a wide pattern of nerve impulses 
generated by the brain. More specifically, the transmission of pain from the peripheral nerve 
through the spinal cord is subject to modulation by both intrinsic neurons and controls being 
driven from the brain39.  In infants, the brain’s ability to modulate pain is limited due to the 
immature nervous system and limited cognitive capabilities 41. Therefore, a fundamental starting 
point for conceptualizing infants’ pain assessment is the recognition of infants’ reliance on the 
caregiver 42. Furthermore, the socio-communication model of infant’s pain 31 asserts that infants’ 
pain should not be interpreted outside the context of the caregiver.  
In the past 2 decades, about 30 pain assessment instruments for infants were developed 43-
45. The early pain assessments instruments for neonates were uni-dimensional including only 
behavioral dimensions such as facial activities 46-48, or body movements49. Uni-dimensional 
physiological indicators and biomarkers were proposed as well 45. Anand and Craig 50 assert that 
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during this past 2 decades of pain assessment development, the scientific community also came 
to realize that physiological response to pain are evidence of pain and not just a ‘surrogate 
measure’ of pain. The most common bio-marker used is cortisol. Cortisol levels as a stress 
response can be measured during pain exposure through saliva. A number of studies have 
shown that salivary cortisol levels of hospitalized preterm infants are higher than in healthy 
infants 51-54. However, the cortisol literature is inconsistent with some studies reporting higher 
levels 55 during pain response of preterm infants and others reporting lower levels 52,56 or no 
changes 20. The use of this method has been limited to research, as results cannot be provided 
rapidly in the clinical setting. An additional physiological measure is the Near-infrared 
spectroscopy (NIRS). Studies in adults and preterm infants have shown that painful stimuli lead 
to activation of specific cortical and subcortical areas, including circulatory and metabolic 
mechanisms 16,63. NIRS is a non-invasive technique that can detect specific hemodynamic 
responses in the somatosensory cortex produced by painful and tactile stimuli 16,57,58.  This 
technique was assessed as a measure of pain in preterm infants in only three published studies 
16,57,59. Another sub-analysis of the parent study compared pain responses measured by NIRS and 
other physiological measures, i.e. heart rate and oxygen saturation (Gerull et al., manuscript in 
preparation). The main limitations of NIRS are primarily related to its lack of feasibility in the 
clinical setting as a pain assessment method and its’ limited ability to filtrate artifacts. Other 
physiological measurements that have been used alone to measure pain are heart rate 60, heart 
rate variability 61, vagal tone 62 (measured through heart rate), oxygen saturation 63,64, 
respiratory rate 60,65, and blood pressure 65. While many physiological measures are available for 
use in studies of neonatal pain responses, they are index measures of reactivity and not direct 
measures of pain 45. No single marker is able to capture all aspects of neonatal pain. In addition 
to the need to measure multiple behavioral and physiological parameters when assessing pain in 
infants, there is evidence to suggest that environmental and medical factors influence pain 
responses in preterm infants 24,26,66.  
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Based on gate theory and the complex nature of neonatal pain, a multidimensional 
approach is recommended when assessing pain 45. This recommendation is justified given the 
consistently reported low correlations between behavioral and physiological pain indicators 
25,60,67. A multidimensional measurement approach can be achieved by a simultaneous 
employment of objective (physiological) and subjective (behavioral) components 68,69, and by 
using a multidimensional approach within a particular measurement domain (e.g. 
multidimensional behavioral measure that include grimacing, cry, and body movements 70-72). 
However, these measures vary widely in relation to the extent to which their psychometric 
properties have been examined, as well as their clinical feasibility and utility 73. Moreover, a 
large proportion of these pain measures have been developed for research purposes, which 
makes them less feasible for use in the clinical setting 74. The most widely used, valid and reliable 
(Cronbach’s alphas range: α = 0.59–0.76 for the different items) composite pain assessment 
instrument in the clinical setting and research is the Premature Infants Pain Profile (PIPP) 68,73. 
The PIPP is a multidimensional pain assessment instrument that includes 3 behavioral facial 
indicators, 2 physiological indicators (heart rate and oxygen saturation), and 2 CFs (GA and 
sleep-awake state). Stevens et al. 73 recently reported, in a review, that the PIPP was used in 59 
studies from 1996 to 2009 and conclude that it remains reliable and valid as an outcome 
measure in pain interventions study. Nevertheless PIPP is not recognized as “gold standard” for 
pain assessment. In Switzerland, clinical setting uses the Bernese Pain Scale for Neonates 
(BPSN). The BPSN is a validated pain assessment instrument for term and preterm neonates, 
which was developed by nurses of a NICU in the capital city of Switzerland, Bern 69. The 
uniqueness of the BPSN is that its development was a clinical initiative, based on recognition for 
the need for a more comprehensive pain assessment instrument. One of the limitations of PIPP is 
that facial activity is the only behavioral indicator measured. The use of only facial indicators can 
hamper pain assessment when the infant is mechanically ventilated or treated with CPAP. The 
BPSN was developed to address this limitation by including additional behavioral indicators (in 
addition to crying and facial expression). The additional behavioral indicators are consolation 
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(time needed to comfort/calm the infant), sleep quality, and posture. In our study, pain was 
assessed with the BPSN. In a feasibility study performed prior to the comparative effectiveness 
study, the BPSN was compared with the PIPP 20. Interrater reliability for the BPSN was similar to 
the PIPP (Cronbach’s alphas range α = 0.69–0.99 and 0.60–0.99 respectively). While there is 
evidence to support the reliability and validity of both the PIPP and BPSN, there are still 
concerns about their sensitivity in very preterm infants.  One of the reasons for limited 
sensitivity is likely to be influence of CFs on preterm infants‘ pain responses.  While the PIPP 
does incorporate two CFs (gestational age behavioral status in terms of sleep/awake status), the 
BPSN does not include one (sleep/awake status).  However, research findings in relation to 
which CFs need to be incorporated into pain assessment instruments are mixed, including 
findings in relation to the two CFs incorporated into the PIPP 19.  
The non-specificity of various pain indicators is a challenge for pain assessment in infants. 
One of the issues is that the individual behavioral and physiological indicators might also be 
present/abnormal for reasons other than pain. Investigators have examined the relationship 
between behavioral pain indicators and cortical hemodynamic activity in response to noxious 
stimuli using NIRS. Slater et al. 59 compared NIRS and the PIPP in preterm infants. They reported 
an overall significant correlation between somatosensory cortical hemodynamic activity and 
PIPP scores (correlation coefficient = 0.72, p = 0.001). However, at 13 out of 33 measurement 
points, infants with cortical responses did not display facial changes resulting in low PIPP scores 
that could be interpreted as infants having no pain or pain of low severity. These findings are 
consistent with the findings of Johnston et al. 26 who reported that approximately 20% of infants 
did not respond behaviorally or physiologically to a painful stimulus. Cortical activation is a 
promising indicator of acute pain in infants but still needs to be validated adequately across 
infant populations and procedures 73. Future research is needed to compare findings of 
composite measures such as the BPSN and PIPP with NIRS in order to affirm these results. 
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There is evidence suggesting that CFs can impact some pain responses 75. Based on 
previous studies and the results of our study (chapter 6), CFs may not impact behavioral and 
physiologic responses in the same way. Grunau and collogues 24 found that GA was negatively 
associated with behavioral pain response measured by the Neonatal Facial Coding System 
(NFCS), while it was positively associated with physiological response measured by heart-rate 
variability. They found the same direction of associations with the number of painful 
procedures. Findings in relation to the impact of CFs on both behavioral and physiologic 
responses are inconsistent.  While there is more support in the literature for selected CFs such 
as GA and the previous painful exposure, findings in relation to their direction of association are 
not consistent. Methodological issues such as the age ranges of infants in the studies, other CFs 
that were also examined and the method of data analysis may be one explanation for the 
inconsistencies reported across studies. These issues support the need for additional research 
examining the impact of CFs on preterm infants‘ pain responses using different methods in order 
to find consistent effect. Future studies should examine the relationship between severity of 
illness in multivariate models that include other variables such as PMA and prior pain exposure 
to determine if it’s independently related to pain responses in preterm infants. To conclude, CFs 
needs to be examined in a broad standardized way, in order to draw clear implications for 
clinical pain assessment. 
As there are many pain assessment instruments for neonates and no consensus exists 
about which should be used 45, we are not recommending a specific pain assessment tool. When 
assessing pain, health care provider also needs to be aware of several dimension such as the 
time point pain when the infant’s pain is being assessed (e.g., was the infant disturbed prior to 
the painful insult), and the other medical and demographic factors that may impact his/her pain 
responses. We believe that current evidence supports use of multidimensional pain assessment 
instruments. While additional research is needed to identify the specific factors that impact 
behavioral and/or physiologic pain responses, there is evidence that CFs does influence infants’ 
responses to pain and should be incorporated in pain assessment instruments.  Including CFs as 
SYNTHESIS, DISCUSSION, AND CONCLUSION 
150 
integral part of pain assessment process is likely to provide a more sensitive assessment of the 
responses of the preterm infant. Pain scores should be adjusted for the effects of CFs showed to 
be important predictors of pain responses in this population.  Using the number of previous 
painful procedures as an example, if the infant was exposed to X number of painful procedures 
he would get XX points added to his pain score.  
7.1.2 CFs study statistical analysis strategy-which is the right way to go? 
In the analysis of the CFs sub-study (chapter 6) we encountered a major challenge while 
deciding how to conduct the statistical analysis. A decision had to be made about which phase(s) of 
the heel-stick (baseline, heel-stick, and recovery) to include in the analysis. There were a number 
of questions that we considered in planning the analysis.  Should we include the BPSN scores for 
all phases, only phase 2 (heel-stick), or phases 2 (heel-stick phase) and 3 (recovery phase) as the 
outcome in the regression model? Should we calculate changes scores between phases? It was 
challenging to decide since the strategy used in previous studies varied. While some studies 
focused on only the heel-stick phase, other studies used two (baseline and heel-stick) phases, and 
some three (baseline, heel-stick, and recovery) to six phases (baseline, contact, swab, heel-stick, 
squeeze, and recovery).  
In the first analysis we performed, we included all phases by computing an average score 
across the 3 phases in the mixed regression model. None of the CFs examined were significantly 
related to total BPSN scores.  GA at birth and PNA were not significantly related to either 
behavioral or physiological scores. When GA and PNA were combined to form a single variable, 
PMA, it was negatively associated (p = 0.005) with behavioral scores, and positively associated 
(p = 0.01) with physiological scores. The number of painful procedures were negatively related 
to behavioral scores (p = 0.02), but positively associated with physiological scores (p = 0.004). 
Gender (p = 0.001) was positively and mechanical ventilation (p = 0.01) was negatively related 
to physiological scores. When the results were discussed in our research team, we wondered if 
including all phases was the correct approach given that our aim was to examine the 
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associations between CFs and pain responses. Since all infants were not disturbed for 1/2 hour 
prior to the heel-stick and were expected to be free of any pain experience at baseline, we 
questioned the validity of including baseline scores in the calculation of the mean score 
representing the infants‘ pain responses. As a result of this discussion we decided to change 
strategy and performed the analysis with phase 2 (heels-stick) only. The results of this analysis 
were challenging to explain. Total and behavioral BPSN scores were negatively associated with 
patent ductus arteriosus, while physiological BPSN score was negatively associated with 
mechanical ventilation and positively associated with gender and respiratory distress syndrome. 
Therefore, another research group discussion took place, where the question of the strategy was 
discussed again. During these discussions, one of the issues raised was the time needed to 
recover following a painful procedure and the likelihood that recovery scores are influenced by 
the second phase (heel-stick) scores. Including scores across all heel-stick phases was also 
reconsidered. The basis for that discussion was a personal discussion with a neonatal expert 
who recommended including phase 1 (baseline) on the basis that it is also influenced by CFs (Dr. 
Steen Hertel, personal communication, October 14, 2011, Nova Scotia, Canada).  The final 
analytic approach selected for examining the impact of CFs on pain scores was to use the 
average of phase 2 and 3 scores as the outcome (dependent) variable in the final analysis while 
controlling for phase 1 scores.    
In addition to the method utilized to measure pain, other methodological issues need to be 
considered. These issues may account for some of the variability seen in findings across studies 
examining the impact of CFs on pain response in preterm infants. They include how CFs were 
measured, which pain assessment instrument was used to measure pain, study sample sizes and 
how the relationships between CFs and pain responses were analyzed (bivariately or 
multivariately). As supported by our systematic review (chapter 5), the existing literature 
presents a wide variation in the CFs measured, pain assessment instruments, and statistical 
analysis strategies. In order to move science forward and provide clear and robust results 
regarding the CFs influencing pain response, we recognize a need for development of a strong 
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theoretical framework to explain how CFs may influence pain responses in preterm infants. Such 
a framework will provide guidance in CF selection and help to advance science in this area. 
There is also a need for standardized methods of data collection, large sample sizes, and 
consistent use of multivariate approaches when examining the relationships between CFs and 
pain responses.  
The lack of clear guidelines on how to treat pain scores when examining the impact of CFs 
and our findings that the CFs significantly related to pain scores varied with the methodological 
approach we utilized, suggest that some of the variability that we see in the literature in relation 
to the impact of CFs on pain responses in preterm infants may be related to variations in how 
the pain score outcome is calculated. There is a need to get consensus and clear guidelines for 
how to calculate pain scores, including which phases of the procedure (baseline, painful 
procedure, and recovery) should be included in the analysis. 
7.2 PAIN MANAGEMENT OF PRETERM INFANTS,  
THE SOCIO-COMMUNICATION CONTEXT 
Infants’ pain is complex and involves more than the painful intervention itself. In addition 
to the medical and demographic CFs, the familial and social contexts are crucial factors in 
understanding pain as a broad concept. The dynamics between the infant and the caregiver are 
important to take under consideration while assessing and managing neonatal pain 76. To 
explain the complexity of pain in a broad concept of infant, caregiver, family, and community we 
used the Scio-communication Model of Infants’ pain developed by Craig and Pillai Riddell 31. For 
the purpose of this dissertation, where the focus is preterm infants hospitalized in a NICU, we 
modified the model by adding the medical and demographic CFs, and placed the health care 
team and unit environment in the first circle next to the infant (Figure 1). 
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Figure 1: The Socio Communication Model of Infants’ Pain – modified model 
 
 
 
 
 
 
 
 
 
The implementation of evidence based practice regarding pain assessment and management 
is widely recognized and had been addressed in several studies 77-80. Yet, our understanding of how 
the health care provider and organizational factors influence pain management in preterms 
remains a challenge. Stevens et al. 81 have recently carried out a qualitative study, which explored 
147 health care professionals’ perception of the influence of factors at an organizational level on 
pain practice in the NICU. Three themes emerged from the data which captured influences on 
optimal pain practices: 1) culture of collaboration and support for evidence-based practice, 2) 
threat to autonomous decision-making, and 3) complexities in care delivery. The results of this 
study support the modification we have performed to the socio-communication model of infants’ 
pain, placing the institute/unit culture, and caregiver in the first circle influencing pain assessment 
and management in neonates. However, further research is still needed to determine how these 
characteristics impact pain management and to develop and examine the efficacy of interventions 
designed to address these issues.  
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7.3 NON-PHARMACOLOGICAL PAIN RELIEF INTERVENTIONS: 
RECOMMENDATIONS FOR CLINICAL PRACTICE 
As reported in chapter 3 and other studies, preterm infant are exposed to a large numbers of 
painful procedures each day 8,9. Studies have supported the efficacy of NPIs such as sucrose, pacifier, 
breast feeding, skin-to-skin contact, FT etc. for minor painful procedures 14,15. However, little is known 
about the comparative effectiveness of these existing NPIs, moreover, even less is known about their 
effect over time. In the study reported in chapter 3 we found that both sucrose and FT were effective in 
preventing pain over time and that there was little additive value of using both interventions together. 
From a clinical perspective, both sucrose and FT were effective for pain management (achieving BPSN 
pain scores below 10 which results to “no pain”) although sucrose was statistically more effective than 
FT.  Given that both interventions are effective, other issues need to be considered in selecting which 
will be utilized in the clinical setting.  These include the safety of the interventions and the resources 
needed to implement them. Additional research is needed to determine the long-term safety of 
repeated administration of sucrose in this population. The other issue that must be considered in 
clinical recommendations is the staff resources required to implement the interventions.  While FT was 
effective in preventing pain (as evidenced by BPSN scores) and had a small additive effect when 
combined with sucrose during the recovery phase of the heel-stick, it did require more staff resources 
than sucrose alone that was more effective in preventing pain. As discussed in chapter 4, this is an 
important issue for many clinical settings where current staffing levels may be a barrier to 
implementation of this intervention. Rather than rejecting FT as a pain relieving intervention, we 
recommend this intervention to be performed by the parents. In addition to enhancing pain relief, 
parental involvement in the pain management of their infant may enhance bonding. This suggestion is 
supported by Axelin et al. 82 in a recent study examining 23 mothers of 29 preterms regarding their 
different styles of involvement in their child’s pain care. They showed that mothers are willing to 
actively take part of their child’s pain care. Thus, parental participation in FT may be a good option for 
some parents. 
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7.4 CONCLUSIONS  
While great strides have been made in pain assessment and treatment in preterm infants, 
pain management remains a major challenge in this vulnerable population of preterm infants. 
The findings of this dissertation support the efficacy of sucrose over time and recommend it over 
FT. While our findings support the importance of considering CFs as influencing pain responses 
in this vulnerable population, the specific CFs that need to be incorporated into pain assessment 
scales remains unclear. Our findings raise important methodological issues that need to be 
considered as future studies are designed to examine the impact of CFs on the pain responses of 
preterm infants.   
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APPENDIX 
 
 
BERNESE PAIN SCALE FOR NEONATES 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total points for subjective indicators: 21; total overall score: 27 
© Cignacco & Stoffel, Women’s Clinic, Berne University Hospital, 2001 
Bernese Pain Scale for Neonates 
Indicator 0 1 2 3 Score 
Sleeping 
Quiet sleep or 
physiologically alert 
Light sleep with eye 
movement 
Spontaneous waking Cannot get sleep  
Crying Not crying 
Short period of crying 
(less than 2 minutes) 
Increased crying 
(more than 2 minutes) 
Increased, shrill crying 
(more than 2 minutes 
 
Consolation 
No consolation 
necessary 
Consolable in less than 1 
minute 
More than 1 minute 
needed for consolation 
Not consolable for more than 2 
minutes 
 
Skin color Pink Plethoric 
Slightly pale, possibly 
Mottled 
Pale, mottled, bluish  
Facial expression Face relaxed Brief grimace 
Increase grimace and 
trembling of chin 
Permanent grimace of face and 
trembling of chin 
 
Posture Body relaxed 
Mainly relaxed, short bouts of 
tension 
Frequent bouts of 
tension but relaxation 
possible 
Permanently tense 
 
Breathing 
Normal and regular 
(baseline) 
Superficial; increase in rate by 
10-14 within 2 minutes 
and/or retractions 
Superficial; increase in 
rate by 15-19 within 2 
minutes; more frequent 
retractions 
Superficial and irregular; 
marked increase in rate by 20 
or more within 2 minutes 
and/or marked retractions 
 
No pain: 0 - 8 points 
Pain:  9 points 
TOTAL FOR SUBJECTIVE 
INDICATORS  
 
Heart-rate Normal (Baseline) 
Increase of 20 bpm or more 
over the baseline with 
return to baseline within 2 
minutes  
Increase of 20 bpm or 
more over baseline 
without return to 
baseline within 2 
minutes 
Increase of 30 bpm or more 
over baseline or more frequent 
episodes of bradycardia within 
2 minutes 
 
Oxygen 
saturation 
Decrease of 0% to 1,9% Decrease of 2% to 2,9% Decrease of 3% to 4,9% Decrease of 5% or more. 
 
No pain: 0 – 10 points 
Pain:  11 points 
OVERALL TOTAL  
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Jerusalem, Israel 
2004 - 2005 ADVANCED COURSE OF CLINICAL INSTRUCTION  
Hadassah School of Nursing, faculty of medicine, Hebrew University, 
Jerusalem, Israel 
UNDERGRADUATE 
1999 - 2003 BACHELOR OF SCIENCE IN NURSING & REGISTERED NURSE IN GENERAL NURSING 
Hadassah School of Nursing, faculty of medicine, Hebrew University, 
Jerusalem, Israel 
1994 – 1997  ABITUR – MATRICULATION CERTIFICATE 
Rabbai Baharn Religious High School for Girls, Kfar Eliyahu, Gedera, 
Israel. 
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APPOINTMENTS AND POSITIONS 
2009 – to present Research assistant and doctoral student, Institute of Nursing Science, 
University of Basel, Switzerland. 
05-09/2007 Long term follow up clinic nurse in the pediatric hematology- oncology 
unit (in addition to other duties in the unit). 
2005 – 2008 Clinical supervisor at the Hadassah Ein Kerem pediatric hematology- 
oncology unit. 
2003 – 2008 Staff nurse at the Hadassah Ein Kerem pediatric hematology- oncology 
unit. 
PROFESSIONAL EXPERIENCE 
2009 – to present  Research and teaching assistant, and organization of a pediatric 
conference at the Institute of Nursing Science, University of Basel. 
2006 – 2008 Member of the unit’s palliative team, and member of the unit’s leadership 
group. 
2003 – 2008 Certified full time nurse at the pediatric hematology-oncology unit.  Shift 
manager since September 2004. Responsible for developing pain 
management protocol in the unit, as well as writing protocols for other 
relevant topics for the unit. Responsible for clinical instruction and 
introducing new nurses to the procedures of the unit. 
2001 – 2003 Nurse assistant during nursing studies at the Hadassah Ein Kerem 
hospital department of pediatrics. 
PARTICIPATION IN PROFESSIONAL CONFERENCES 
2011 8th International Forum on Pediatric Pain, New Concepts in Complex and 
Recurrent Pain (IFPP) which took place in Nova Scotia, Canada (October 
2011, Poster presentation) 
2011 2nd Symposium of the Swiss Clinical Trial Organization, Clinical Research 
in Pediatrics (SCTO) which took place in Basel, Switzerland (June 2011, 
Poster presentation) 
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2011 `Assembling Health`: Challenges in Research and Treatment of Complex 
Health Conditions which took place in Haifa, Israel (March 2011, Poster 
presentation) 
2010 The 3rd congress of the European Academy of Pediatric Societies (EAPS) 
which took place in Copenhagen, Denmark (October 2010, Poster 
presentation) 
AWARDS AND SCHOLARSHIPS 
2010 Scholarship for participation at the International Multi-Professional 
Pediatric Palliative Care Course in Haltern, Germany 
2009 – 2012 Grant for PhD studies at the University of Basel funded by the BOTNAR 
foundation.  
2009 Grant for PhD studies from Hadassah University Hospital, Jerusalem, 
Israel. 
2008 Excellence scholarship from the Eve Rosen Lieberson Nursing Scholarship 
for MScN studies. 
2006 Nominated for the oncology unit’s Itay Ramon Foundation exceptional 
nurse award at Hadassah Ein Kerem 
RESEARCH 
2009 – 2012 PAMINA (PAin Management In neoNAtes) project. Testing the efficacy of 
pain relieving non-pharmacological interventions in preterm infants 
undergoing repeated heel-sticks in neonatal intensive care units. A pilot 
randomized controlled trial 
2009 – 2012 Contextual factors associated with pain response of preterm infants 
receiving non-pharmacological pain relief interventions for heel-stick 
procedures.  
2008 Study nurse of a randomized cross-over study of curcumin for prevention 
of oral mucositis in children receiving Doxorubicin based chemotherapy. 
2006 – 2009 Master thesis on body image and sexual self-perception in young adults 
who have completed treatment for a malignant illness 
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PUBLICATIONS 
PEER REVIEWED JOURNALS 
2013 Sellam G, Engberg S, Denhaerynck K, Craig DK, Engberg S. Contextual 
factors associated with pain response of preterm infants receiving non-
pharmacological pain relief interventions for heel-stick procedures. The 
European Journal of Pain, 2013;17:255-263. 
2013   Gerull R, Cignacco EL, Stoffel L, Sellam G, Nelle M. The influence of non-
pharmacologic analgesic interventions in preterm infants on physiologic 
parameters: a randomized trial. Resubmitted on February 2013 to the 
Neonatology.  
2012 Cignacco EL, Sellam G, Stoffel L, Gerull R, Nelle M, Anand KJS, Engberg S. 
Oral sucrose and ‘facilitated tucking’ for repeated pain relief in preterms. 
A randomized controlled trial. Pediatrics 2012;129:299-308. 
2011 Sellam G, Cignacco EL, Craig KD, Engberg S. Contextual factors influencing 
pain response to heel-stick procedures in preterm infants: What do we 
know? A systematic review. European Journal of Pain, 2011;15:661 e1- e15. 
2011 Elad S, Meidan I, Zeevi I, Sellam G, Saman S, Waldman E, Wientraub M, 
Revel-Vilk S. Randomized cross-over study of curcumin for prevention of 
oral mucositis in children receiving Doxorubicin based chemotherapy. 
Submitted on December 2011 to the Journal of Alternative Therapies in 
Health and Medcine. 
2010 Cignacco E, Axelin A, Stoffel L, Sellam G, Anand KJ and Engberg S. 
Facilitated tucking as a non-pharmacological intervention for neonatal 
pain relief: Is it clinically feasible? Acta Paediatr 2010; 99, 1763–1765. 
 
OTHER JOURNALS 
2011 Sellam G, Schulz C, Hammerli NS, Cignacco E. [Neonatal intensive care: 
optimizing pain management in newborn infants]. Krankenpfl Soins 
Infirm 2011;104:32-3. 
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LEADERSHIP PROJECT 
2010 – 2012 Conceptualization and co-organization of conference: Challenges in 
Pediatric Care: Innovations through Advanced Nursing Practice, taking 
place on January 13th, 2012 in Basel, Switzerland. 
TEACHING EXPERIENCE 
2009 – 2012  Quantitative Research course. Lectures for bachelor students of the 
Institute of Nursing Science, University of Basel, Switzerland  
2009-2011 Quantitative Proposal Writing Seminar. Lectures for master students of 
the Institute of Nursing Science, University of Basel, Switzerland  
2009-2011 Quantitative Master Seminar. Lectures for master students of the Institute 
of Nursing Science, University of Basel, Switzerland  
